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O presente documento pretende descrever um estágio curricular realizado na 
clínica Lenitudes Medical Center & Research, localizada em Santa Maria da 
Feira, que decorreu durante 10 meses, acompanhando o processo de 
construção, abertura e entrada em funcionamento desta nova estrutura de 
saúde.   
 
A formação académica proporcionada pelas unidades curriculares do Mestrado 
em Biomedicina Farmacêutica permitiu o desenvolvimento de conhecimentos e 
competências nas áreas de Investigação Clínica, Regulamentação e 
Desenvolvimento de Dispositivos Médicos e Gestão da Qualidade que 
puderam ser colocados em prática durante esta experiência.  
 
O estágio focou essencialmente tópicos relacionados com a Gestão da 
Qualidade, com os respetivos processos de desenvolvimento do seu Sistema e 
da respetiva documentação, visando possíveis estratégias futuras para a 
Acreditação e Certificação desta unidade de saúde. Durante o estágio, 
adicionalmente, foram realizadas atividades de carácter multidisciplinar 
relacionadas com a procura, organização de propostas de orçamento e 
seleção de dispositivos médicos e, ainda, alguns processos iniciais de 
investigação clínica.  
 
O estágio curricular revelou-se bastante enriquecedor e único, tendo permitido 
o desenvolvimento de novas competências e aptidões profissionais, pessoais e 
sociais.  
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This document aims to describe a traineeship developed in the healthcare unit 
Lenitudes Medical Center & Research, located in Santa Maria da Feira, which 
had a duration of 10 months, following the process of construction, opening and 
start functioning of this new health facility. 
 
The academic training provided during module courses of the Master Degree in 
Pharmaceutical Biomedicine allowed the development of knowledge and skills 
in the areas of Clinical Research, Regulatory and Medical Devices 
Development and Quality Management which have been put into practice 
during this experience.     
 
The traineeship focused, essentially, on topics related to quality management, 
respective documentation and development processes of its system, with the 
objective to outline future strategies for this clinic’s accreditation and 
certification. During this traineeship, I additionally developed multidisciplinary 
activities related to search, organization of medical devices’ budgets and 
selection and, also, some initial processes regarding clinical research.   
 
The traineeship has proved very enriching and unique, having enabled the 
development of new professional, personal and social skills.   
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1 Introduction 
This document describes the activities and skills developed during the traineeship in Lenitudes 
Medical Center & Research (Lenitudes MC&R), within the scope of the master’s degree in 
Pharmaceutical Medicine. The formal traineeship period started in 15th of September and ended in 
17th of April, although the contact between both parts begun earlier, in 2nd of June. Since the clinic 
is a new healthcare unit built from scratch, I had the opportunity to follow its creation and 
development from early on the process.  For that reason, the majority of the traineeship activities 
were performed in provisory installations in Hotel Ibis, in Sta. Maria da Feira, watching from close, 
the progression and evolution of the clinic’s construction and equipping.  
The main core of this report and the traineeship were tasks related to quality management 
including the collaboration on the development of Standard Operating Procedures (SOP), creation 
of record standards, development of the quality management plan which included strategies to 
create and improve the quality management system and strategies for accreditation and 
certification. Nevertheless, several trainings on quality management and other activities were 
performed, such as activities of administrative nature, management, contact with medical devices’ 
suppliers and tasks related to clinical research.  
1.1 Objectives 
The traineeship objectives were divided into those needed to conclude the master’s degree, those 
related to collaboration on the projects and work within the host company, and finally, the aims 
related to personal development.  
Thereby, the following represent the goals required for master’s conclusion: 
 To develop the plan for quality management of the host company; 
 To start the creation of the quality management system; 
 To collaborate on the creation of SOPs; 
 To understand the National health Accreditation Programme; 
 To understand other Accreditation models such as Joint Commission International (JCI), 
Caspe Healthcare Knowledge Systems (CHKS) and Organisation of European Cancer 
Institutes (OECI); 
 To know the International Organization for Standardization (ISO) standards applicable to 
healthcare services’ units and certification processes; 
 To collaborate on the assurance of company’s compliance with regulatory clinical 
legislation and applicable standards; 
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 To know the regulatory national legislation related to private healthcare units; 
 To know the regulatory national legislation applicable to nuclear medicine and 
radiotherapy services; 
 To know the medical devices’ market, specifically the medical devices’ suppliers; 
 To face the health market and the reality within a healthcare unit. 
Regarding the host company, adding to the previous referred, the following objectives were 
defined:  
 To collaborate on documentation organization and record; 
 To collaborate on the request, record, organization, review and management of the 
hospital equipment and medical devices’ budgets; 
 To collaborate on the equipment selection processes; 
 To understand the quantity and types of medical devices that a healthcare unit with the 
Lenitudes MC&R’s characteristics, needs to open and to start operating; 
 To know the basic requirements and characteristics of each medical device needed in the 
clinics’ services; 
 To understand the material and human resources that are required for this healthcare unit. 
Personally, I identified the following personal aims to be achieved at the end of the traineeship: 
 To be adapted to professional life and to clinical environment; 
 To be prepared to face the labour market; 
 To recognize my difficulties and strengths and to improve it;  
 To have been able to contribute to the success of the projects were I was involved and to 
the company’s success; 
 To put into practice the knowledge and skills developed during academic training; 
 To make connections with people on this sector; 
 To increase my knowledge, to grow both professionally and personally. 
1.2 Host Organization Portrait 
As I referred previously, my traineeship was developed in Lenitudes MC&R, which is a subunit of 
Lenitudes SGPS company. 
Lenitudes SGPS is the holding enterprise, located in Lisbon, which includes four other companies 
related to healthcare services. This holding company comprises the departments of 
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administration and general management of all the other units involved, project management and 
legal support.  
Lenitudes holds the following units (figure 1 and 2): 
 Lenicare was the first establishment to open and to start operating and it is a radiotherapy 
unit located in Évora, being a public-private partnership with the Lenitudes and Hospital do 
Espírito Santo – Évora.  
 Lenitudes Medical Center & Research, in Sta. Maria da Feira, was my host company that 
started being constructed right after Lenicare, and its characterization and further details 
will be referred further on.  
 The “Hospital Cirúrgico de Setúbal” and “Hospital Portimão” are the units which will be 
developed after Lenitudes in Sta. Maria da Feira has opened and started operating.   
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Lenitudes 
Medical Center and Research 
 
 
Lenitudes SGPS, SA 
Lisboa 
 
 
Lenitudes SGPS, SA 
 
 
 
Lenitudes MC&R 
 
 
Lenicare 
 
Hospital Cirúrgico de 
Setúbal 
Lenicare – Évora 
 
 
Hospital de Portimão 
Figure 2 - Lenitudes units’ Location 
Hospital Cirúrgico Setúbal Hospital Portimão 
Figure 1 - Lenitudes SGPS Representation and its clinical units 
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1.2.1 Lenitudes Medical Center & Research 
Lenitudes MC&R was the unit that followed the Lenicare’s creation. The construction phase 
ended in January 2015 (figure 3), enabling the occupation of the clinic’s space and the 
subsequent change of the employees from the temporary facilities - Hotel Ibis - to the clinic.  
 
 
 
Figure 3 – Lenitudes’ building image 
 
The internal structure of the company is represented in figure 4. 
As it is shown, Lenitudes MC&R belongs to Lenitudes’ group, being administered by some 
members of this holding company. Prof. Francisco Pimentel, my host training supervisor, is 
responsible for Lenitudes MC&R’s clinical leadership.  
As for my traineeship, it occurred in a time where departments and divisions were not defined 
yet. However it can easily be included in clinical devices/supplies’ management and quality 
management, being presented in figure 4 in yellow colour.   
There are some services that are performed by outsourced companies, such as: 
 Human resources for Radiotherapy and Nuclear Medicine (except specialist physicians); 
 Hygiene and cleaning;  
 The sterilization of the surgical and medical instruments and devices;  
 The service of waste management;  
 The laundry services. 
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Lenitudes SGPS, SA
Lisboa
Lenitudes MC&R
Admnistration Council
Technical Commissions
Oncological 
Coordination
Ethics Committee
Pharmacy Commission
Hospitalar Infections 
Control Commission
Quality
Clinical Leadership: 
Professor Francisco 
Pimentel
Clinical
Medical Specialtities 
Oncology
Radiotherapy
Nuclear Medicine
Imagiology
Surgery
Nursing
Superior Technicians
Pharmacy 
Sterilisation
Laboratories (Clinical 
pathology, Patologic 
Anatolmy and 
Imunohemotherapy)
R&D
Clinical Research
Data Management
Management
Secretary
Human Resources
Financial
General Management
Morgue
Provision and Supplies
Equipment 
Maintenance
Hygiene and Cleaning
Figure 4 - Lenitudes MC&R organisation chart’s proposal 
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This centre located in Sta. Maria da Feira presents a range of clinical services, from diagnose 
techniques to clinical treatments: 
  Nuclear Medicine with two different equipment: one positron emission tomography 
(Pet) and one gamma camera single photon emission computed tomography (SPECT); 
 Imaging: echography, radiology and mammography, specifically two echo graphs, one 
echocardiograph, one mammography, one image intensifier and one computerized 
tomography (CT); 
 Radiotherapy: with two accelerators machines; 
 Outpatient Surgery: two surgical rooms plus three recovery areas including four 
bedrooms;  
 Chemotherapy (medical oncology): with four individual rooms and one larger room for 
three or four patients; 
 Consultations rooms: one for psychology and nutrition and eight for the following 
medical specialties: 
o Gynaecology/urology; 
o Otorhinolaryngology; 
o Neurology; 
o Gastroenterology; 
o Anaesthesiology and Pain; 
o Orthopaedic; 
o Psychiatry; 
o Dermatology; 
o Radiotherapy;  
o Nuclear Medicine; 
o Cardiology; 
o Pulmonology; 
o Medical Oncology; 
 Oncology Research within two laboratories: one for basic research and another specific for 
clinical research; 
 Palliative care and partnerships with other clinical centres. 
Lenitudes MC&R has the ultimate technology, from General Eletrics, corresponding to the 
cutting-edge technology. In terms of diagnose, the equipment of nuclear medicine includes the 
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new PET/CT that are only available in two more places worldwide, offering a better image in less 
time with a much lower dose of radio drugs. The SPECT, the general echo graph, the ultimate 
model of echocardiograph and the surgery X-Ray arch C are also cutting-edge devices.  
In terms of radiotherapy, Lenitudes MC&R will offer a more precise treatment, since the two 
Elekta accelerators produce a more accurate radiation beam, in a fewer time, causing less 
collateral damage. Therefore, the healthy cells located near the tumour will hardly be affected.  
Lenitudes MC&R will also be the training centre of the Iberian Peninsula and the Lusophone 
world for these devices.   
Regarding the surgery, this clinic will use advanced surgical techniques, and even irreversible 
electroporation procedures. It is going to have the surgical rooms equipped with high technology 
which will be used by multidisciplinary surgical teams.  
Concerning clinical consultations, there will be created geriatric oncology specialised 
consultations.  
On the other hand, the management and clinical assessment of the outcomes generated are 
also an outstanding method that will allow Lenitudes MC&R to provide a more personalised 
treatment to each patient, evaluate better the progression or regression of the disease in each 
patient, in a context of a more personalised medicine, to which the advanced diagnostic devices 
will also contribute.   
The figure 5 represents the Lenitudes’ drawing, with the areas and services that it will offer.  
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Figure 5 - Lenitudes MC&R's drawing (1 - Reception, 2 - Consultation/Examination rooms, 3 - Nuclear Medicine 
and Molecular Imaging, 4 - Imagiology, 5 - Radiotherapy, 6 - Surgery, 7 - Day Hospital, 8 - Administration and 
Research & Development) 
 
Lenitudes MC&R unit pretends to focus and maintain the core in oncological patients and 
treatment. However it presents more valences: the nuclear medicine devices can be used to 
diagnose other diseases, the consultations rooms are meant for medical specialties other than 
oncological, and there is the possibility to perform endoscopic and surgical procedures to other 
pathologies than cancer. This unit will go even further by offering sleep studies, clinical trials, 
cardio and neurologic research related to nuclear medicine techniques.  The outcomes of each 
treatment and procedure will be assessed in order to give more representative, valuable and 
reliable data.  
Lenitudes MC&R is also very committed on the quality of the services and its continuous 
improvement, ensuring the satisfaction of the patient’s expectations and needs.  
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1.3 Reports’ Structure 
This report is organised in order to present, in this chapter, the host company, followed by a 
general framework of health, new cases of cancer and the need for health care with better quality. 
Then, it introduces the subject of Quality Management, identifying and clarifying the accreditation 
and certification models considered for the company in question. In later chapters, it is presented 
and explained my experience and activities. In the Discussion chapter, there is an exhibition of my 
personal opinion, the difficulties I felt and the acquired skills and knowledge.  
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2 General Framework 
In Europe, as well as in Portugal, there has been a demographic evolution and an increase on the 
average of life expectancy. In fact, life expectancy, in Portugal in 2008-2010, presented values of 
76.14 years for man and 82.05 years for women, at birth. This demographic evolution characterized 
by the ageing of population brings particularities in diseases, treatments and in health care [1]. 
This circumstance allied with population’s lifestyle results in the increase on the number of certain 
diseases, such as cancer. Cancer is, undoubtedly, a current disease that will be even more prevalent 
in the future. According to International Agency for Research on Cancer (IARC), in European Union, 
there will be an 13.7% increase on the new cases of cancer, based only on the criterion of the aging 
of population. Concerning Portugal, it is estimated an increase of 12.6% in new cancer cases (Figure 
6 and Figure 7) [2]. 
 
Figure 6 - Estimated evolution on the incidence of cancer in Portugal (2010 to 2030) [3] 
 
 
Figure 7  - Evolution rate on incidence of malignant tumours in Portugal [3] 
In spite of the increase on the number of cases, compared to previous years, the mortality rate has 
been slightly decreasing, showing positive results in healthcare values. Based on the Health 
Direction (Direção-Geral da Saúde – DGS in Portuguese) report “Cancer Diseases in Numbers – 
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2014” [3] there has been an increase on radiotherapy services, on the use of cytotoxic and 
immunomodulating drugs, and on the number of surgeries. Contrarily, there was also a slightly 
increase in standby time for surgery, in public units [2, 3]. These numbers seem to indicate some 
difficulties in this type of care. Because of the fact that the public services cannot provide a full 
coverage of treatments and diagnostic methods to the population, the Portuguese government is 
starting to understand the importance of collaboration with private services, in order to achieve 
more effectiveness and innovation, earlier screenings, improvements on oncological surgeries and 
on the standby times for consultations, treatments and surgeries [2-5].  
In fact, the population are also demanding more technical and human resources, enhancing the 
requirements and needs for each patient [3].   
Additionally, and mainly because of the innovation in treatments and surgeries, the number of 
cancer patients that survive has also been rising, which presents clinical and social particular issues 
demanding more healthcare services. The population is also becoming more health literate, 
demanding health services with high standards of quality [2, 3, 6-8].  
In terms of quality, as it is well known, the majority of companies, independently of the area/sector 
where they are inserted, are very concerned about the quality of their products/services. The 
healthcare units are no exception. As a matter of fact, in Portugal, the public healthcare units and 
their regulatory authorities, DGS and Health Regulatory Entity (Entidade Reguladora da Saúde – ERS 
in Portuguese), are committed to quality in health, accreditation and certification. The regulatory 
authorities are promoting this particular issue by providing conferences and meetings.  The 
Calouste Gulbenkian Foundation released a report “A future for Health”[9] defending the 
promotion, improvement and implementation of quality in health, in order to achieve a sustainable 
healthcare system with high quality. In a time where financial resources are limited, the quality 
management takes a crucial role [9].  
Since the evaluation and assessment of a service to determine if it has quality or not, is very difficult 
and subjective, there were created standards of accreditation and certification.  
In Portugal, the accreditation of health units has already been started fifteen years ago. During this 
time, the programs, objectives and methods were changed and decided. Nowadays, the quality in 
health care plays a greater role [10, 11].  
In spite of the commitment of the public health authorities, in public health care, there is still a lack 
of good quality indicators and objectives and, therefore, on the assessment of quality in health care.  
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The dissemination of information related to quality in Portuguese healthcare services is also not 
being effective. In fact, the American organization “Patients Beyond Borders”, does not have any 
information and knowledge about Portugal, concerning quality and patients’ numbers [12, 13].   
Still, Portugal is creating several incentives to change this paradigm. For instance, the development 
of the “Sim-Cidadão” to analyse and assess patients’ complaints and suggestions related to public 
healthcare services which are very important to achieve improvements in health.   The Central 
Administration of Health System (ACSS) developed quality objectives associated with incentives or 
penalties, in the program-contracts with the healthcare centres and hospitals groups.  
There are another programs that show the commitment for quality, for example the National 
Program for Prevention and Control of Infections Associated with Health Care created by DGS; 
National Incident Reporting System and Adverse Events and Centre for Patient Safety developed by 
DGS; National Campaign for Hand Hygiene within the “World Health Organisation (WHO) World 
Alliance for Patient Safety”; or Project Healthcare Associated Infections in European Long Term Care 
Facilities developed in Project HALT by DGS. 
In terms of international companies that promote quality in health, specifically of accreditation 
there is the international company King’s Fund, the Joint Commission International (JCI) and 
Agencia de Calidad Sanitaria de Andalucia (ACSA). With the focus on patient’s management and 
safety, there is the European Foundation for Quality in Management (EFQM) and European Union 
Network for Patient Safety (EUNetPaS). Particularly to hospitals there is the World Health 
Organisation (WHO) integrating Health promotion into Hospitals and Health services, among 
others. There are also other institutions that promote health quality such as National Institute for 
Health and Clinical Excellence (NICE) in United Kingdom, Haute Autorité de Santé (HAS) in France 
and the German Agency for Quality in Medicine in Germany [12]. 
The Organisation for Economic Co-operation and Development (OECD) is creating the project called 
“Health Care Quality Indicators”, to promote and improve the assessment of quality in health care. 
This project comprises three types of indicators: the structure indicators, related to the conditions 
and requirements that the hospital has and needs to operate, and related to the qualification of 
human resources; the process indicators, associated with the performance of care and if it is 
intended for the target population; and the outcome indicators, which consist on the results of 
medical care related to the improvement or impairment of a certain patient’s condition. OECD 
through “Health at a Glance 2013” [14] presents several health indicators with respective data 
related to health systems from several countries [12, 14]. 
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In Family Health Centres (Unidades de Saúde Familiar (USF) in Portuguese) there are already 
created indicators of performance to assess the availability, accessibility, efficiency, technical and 
scientific quality, effectiveness and satisfaction [12] . 
In Portugal, there are already twenty six healthcare unites certified by the JCI and CHKS[13]. 
Despite that information, based on the study “O Estado de Saúde em Portugal, 2009” that assessed 
the Portuguese opinions, 95% revealed that the national health service needed changes, 
particularly on the standby times, on the organization and management of resources, on 
investment and on quality [15]. 
In reality, there is a trend by patients to search for healthcare services with better quality. 
Therefore, according to some released media papers, the Portuguese people prefer more the 
private services, when compared to previous years. Actually, Portuguese are making more contracts 
with health insurances and using more private healthcare units. According to the Spanish consulting 
company DBK’s report, the companies holding the private healthcare units grew 14% per year from 
2000 to 2005 [16, 17]. 
On the other hand, the health insurance companies are also demanding high quality in the 
associated healthcare units, in order to diminish the risks related to claims and compensations [18]. 
Another important aspect to consider is the health tourism, with the trend to grow higher, and to 
bring profits to national economy. If we check the list of the countries with higher health tourism, 
we will see Thailand with hospital “Bumrungrad International”, which is accredited by JCI [13]. 
Undoubtedly, in order to reach a greater market, internationalization, and to attract patients from 
foreign countries within the scope of health tourism, accreditation and certification are essential. 
To show the quality assurance mark in the services helps to ensure that the clinic is sustainable and 
improves the confidence in the services. This brand is crucial to promotion and marketing of the 
services. Quality also contributes to ensure more profits for the company since it is very important 
to attract more patients. Adding the fact that quality increases collaborators’ motivation and 
satisfaction providing a better service. On the other hand, quality helps to manage more efficiently 
ensuring profitability to the unit.   
Lenitudes SGPS, and Lenitudes MC&R in particular, want to contribute to increase the Portugal 
presence on the international routes of health tourism, applying to quality improvement and 
making efforts to turn Medicine more personalised and reliable.  
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2.1 Regulatory Framework 
 
The new private healthcare units need to comply with several legal requirements. This compliance 
has extreme importance in order to increase the probability of obtaining licences to start 
operating. Therefore, below there are presented some of the regulatory documents consulted 
during the phase of construction and equipping of the clinic: 
 Portuguese Decree-law 127/2014 of August 22th, concerning the opening, modification and 
operation of private health facilities [19]; 
 Portuguese Decree-law 222/2008 of November 17th, that consists of the standards for 
safety and protection for the use of ionizing radiation [20]; 
 Recommendations and technical specifications for hospital units, 2011 by ACSS [21]; 
 Portuguese Governmental Order Number 33/2014 of February 12th, regarding the opening, 
modification and operation of private health facilities [22]; 
 Portuguese Governmental Order Number 34/2014 of February 12th, concerning the 
opening, modification and operation of private health facilities [23]; 
 Portuguese Governmental Order Number 35/2014 of February 12th, related with the 
opening, modification and operation of private health facilities [24]. 
Quality Management is becoming more obligatory and legislated. For the activities related to 
quality management and quality in health, the following regulation was consulted: 
 Portuguese Governmental Order Number 69/2009 of August 31th, that approves the 
accreditation model ACSA as the official and national model for accreditation in health care 
[25]; 
 Portuguese Decree-law 234/2008 of December 2nd, that gave to DGS the skills to plan and 
program the policy for the quality in healthcare system [26]; 
 Portuguese Governmental Order Number 155/2009 of February 15th, the quality in health 
department was created [27]; 
 Portuguese Governmental Order Number 14223/2009 of June 24th that approved the 
National Strategy for Quality in Health care [28]. 
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2.2 Quality Management 
Quality, according to EN ISO 9000:2005 standard, can be defined as the 
“Degree to which a set of inherent characteristics  fulfils requirements” 
EN ISO 9000:2005 (page 7) [29]  
 
There are many other definitions, however, quality is, undoubtedly, “doing right at first time”, in 
an efficient and sustainable way, with the involvement of all collaborators, with focus on 
improvement and on the clients’ satisfaction [30-32].  
Historically, quality is present at least from Egypt ancient time, having become more important 
during the industrial revolution. Europe started being more focused on quality since the eighty 
years with the development of ISO 9000 standards.  Portugal also started giving importance to 
quality management from eighties to nineties with the creation of several entities specific for 
quality aspects  [31, 33, 34]. 
There are certain names which made a great contribution to quality management such as G. 
Taguchi with the focus on the reduction on variation, J. M. Juran with trilogy of quality, K. Ishikawa 
with the importance on Training and Education, P.B. Crosby with the recipe of doing right at first 
time, A. V. Feigenbaum with the three steps for quality and W.E. Deming, with the cycle PDCA and 
the fourteen topics needed to achieve quality, among others [31, 35]. 
Quality management can be define as the activities and actions executed by an entity in order to 
lead, manage and control their procedures, processes and services/products.  
According to ISO standards, there are eight fundamental principles: 
1. Customer Focus: The basis for the success of the companies is satisfying customer needs 
and requirements; 
2. Leadership: This competence is crucial to ensure the engagement of all collaborators and 
the company’s sustainability; 
3. Involvement of People: The collaborators are the ones who perform the service and their 
engagement in quality management and improvement of processes is very important; 
4. Process Approach: The activities and actions must be manage and executed as processes 
by transforming inputs into outputs, in order to generate measurable and efficient results; 
5. System Approach to management: The processes must be manage within a system, in 
which there are inputs which are transformed into outputs; 
6. Continual Improvement: Search and effort for continuous improvement should be an 
enduring practice of the organisations; 
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7. Factual Approach to Decision-making: The decisions, especially in health care must be 
supported by reliable and measurable data; 
8. Mutually beneficial suppliers relationships: The suppliers are important stakeholders, 
therefore, in order to enhance quality in both processes and systems, both must work and 
relate beneficially; 
In a generic point of view, and taking as basis the figure 8, the model of quality management 
encompasses the inputs, which consist of the customer’s requirements and needs that are 
transformed through the process of development of the service/product into outputs which 
include the costumer’s satisfaction. In this cycle there is also the contribution of data 
measurement, analysis and improvement processes, resources management and leadership and 
management responsibility [30, 32, 36]. 
The processes approach model is presented next: 
 
Figure 8 - Representation of a Processes Approach Model [36] 
 
In fact, the customers are the key to quality management and continuous improvement: 
“Your most unhappy customers are your greatest source of learning” 
       Bill Gates, founder of Microsoft 
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In order to achieve the continuous improvement, the processes related to development of the 
service and the quality management should obey to Deming’s cycle, also known as the PDCA 
method, including the following steps (figure 9): 
 P “Plan” – To identify the customer’s requirements and needs, to determine the policy and 
objectives for quality within the company, to identify the processes needed to achieve 
those aims; 
 D “Do” – To perform those pre-identified processes and procedures; 
 C “Check” – To measure, analyse and manage the outcomes of the processes, in comparison 
with the customer’s requirements, and the policy and objectives of the company; 
 A “Act” – Having as basis the analysis previously performed, improve the processes and the 
outcomes [30]. 
 
Figure 9 - Deming's cycle [37] 
To sum up, quality management requires, firstly, the planning, followed by control and analysis, 
assurance and continuous improvement [30-32, 34]. 
The EFQM Excellence model is also an important tool to achieve quality. It can be applied to any 
organisation, presenting nine criteria, having five “enablers” criteria that refer to “what and how” 
the company does, and four “results” criteria regarding “what” the company achieves. The first 
topic of criteria includes subtopics such as leadership, people, strategy, partnerships, resources, 
processes, products and services. These if well implemented, will result on the following 
subtopics: people results, costumer, society and business (figure 10).  
This model is based on 3 pillars: learning, creativity and innovation [38]. 
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Figure 10 – EFQM Excellence model [38] 
In healthcare units, it is important to focus not only on quality, but especially on patient’s safety 
and well-being. Quality of care is essential to improve health outcomes [10, 39]. 
It is also relevant to state that quality should not be focused in a few areas but in all units’ 
organization and structure, infrastructure and mainly in the clinical aspects.  
It is extremely important to ensure that medicine is being practised according to high standards 
and criteria of quality, value, precision and accuracy [10]. 
 
2.2.1 Accreditation 
Accreditation is the process from which an external organisation recognises that Applicant 
Company is able and has technical competence to perform compliance assessment activities 
[31, 40]. 
The healthcare sector presents certain particularities, being the accreditation process defined 
as the evaluation and recognition that a healthcare organisation meets applicable and pre-
identified standards, by an external organisation. Usually, accreditation process applies to the 
entire company [41, 42].  
By saying that, it is clear that accreditation have high importance for the brand and image, 
enhancing the costumer’s confidence and contributing to differentiate from the competitors.  
There are some organisations that offer accreditations programmes, as referred before, based 
on Portuguese National Health Accreditation Programme: CHKS, JCI and ACSA. The OECI was 
also considered. 
In the next sections these organisations will be detailed and clarified [10, 43, 44]. 
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2.2.1.1 Caspe Healthcare Knowledge Systems (CHKS) 
This organization belongs to the holding company named “Capita”, which presents a great 
presence on the processes management of business in United Kingdom, being also present 
on the European, African and Indian market.  
CHKS encompasses two big distinct areas: “Data and Consultancy” by providing support on the 
identification and measurement of healthcare performance indicators; and “Accreditation” 
programmes, being present in more than a hundred healthcare units, in Europe.  
This company is accredited by International Society for Quality in Healthcare (ISQua) standards 
and by United Kingdom Accreditation System (UKAS) for ISO Standard 17021:2011, which gives 
them the ability to certify other organisations by ISO 9001:2008 standard. This way, CHKS can 
provide accreditation or accreditation plus certification for ISO 9001:2008. Thereby, CHKS 
ensures a complete programme, certification focused on the quality management system 
(QMS) and accreditation specific for clinical issues and indicators and patient’s safety.  
CHKS presents several accreditation programmes with different requirements, specific for the 
following areas: 
 “Addiction Treatment Centres; 
 Care Homes; 
 Hospices; 
 Full Hospital Accreditation; 
 Mental Health Providers; 
 Primary Care Teams; 
 Oncology Services; 
 Risk and Patient Safety; 
 Leadership and Corporate Management; 
 Maternity and Neonatal Care.” 
The programme provided by CHKS, usually, needs fifteen months, from the acceptance of 
contract, followed by training and questions sessions, audits and delivery of final report. The 
“award” is granted to the companies that are in compliance with CHKS’s requirements, and 
can be kept for three years. Then, a new evaluation is needed.  
CHKS, already, made accreditation processes in Portugal, in oncology sector, specifically in 
Portuguese Oncology Institute (IPO) of Porto and IPO-Coimbra. The table 1 presents the 
structure and the standards listing of the Oncology Programme.  
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Table 1 - CHKS's Oncology programme standards listing 
Section 1: Service Delivery Standard 1 – Departmental and service management 
Standard 2 –  Quality Management 
Standard 3 – Risk  
Standard 4 – Competent Workforce 
Standard 5 – Information governance and technology 
Standard 6 – Clinical Records Management 
Standard 7 – Patient Focus 
Standard 8 – Administration and clerical services 
Section 2: Clinical Services Standard 9 – Radiotherapy  
Standard 10 – Radiotherapy Physics 
Standard 11 – Chemotherapy  
Standard 12 – Outpatient Clinics  
Standard 13 – Clinical Trials 
Standard 14 – Treatment of children and young people 
 
For each of the standards presented above there are several requirements that must be 
fulfilled [10, 43, 45-47]. 
 
2.2.1.2 Joint Commission International (JCI) 
Joint Commission was created in 1951, consisting of a non-profit organization, which made 
part of accreditation processes of more than 20.500 healthcare units.  
The JCI, founded on 1994, is integrated in “Joint Commission Resources”, being part of the 
Joint Commission on Accreditation of Healthcare Organizations (JCAHO). JCI, with 
accreditation processes, specifically, is spread worldwide among more than ninety countries.  
The JCI’s main purposes are the patient’s safety and quality improvement in health care. The 
programme includes several international standards that are associated to measurable 
elements to evaluate the compliance.  
This process, in spite of being created by a foreign company, it is fully in compliance with the 
legal, religion and cultural specificities of each country.  JCI reviews its own standards in periods 
of two years.  
The standards can be classified into mandatory or optional, being checked and evaluated 
during the JCI’s audits.  
After JCI’s assessment, there can be two decisions: 
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 Accredited: if the applicant company showed minimum results of compliance for all 
mandatory and optional standards; the company receives the final report and a 
“award”; 
 Accreditation denied: When the applicant company didn’t show fulfilment of the 
requirements, or when the company withdraw or even when JCI decides to remove the 
accreditation decision. 
This way, for each requirement, the organization can be classified as “Fully complies”, 
“Complies partially” or “Does not comply”. 
If an organization is classified with “Does not comply” for certain requirements, there can be 
developed “follow-up activities” to improve it.  
The accredited organisations must renew their award in a period of three years.  
JCI also presents several healthcare programmes, however, for the purpose of this report, the 
only one taken into consideration is the “Joint Commission International Accreditation 
Standards for Ambulatory Care”.  This programme can be summarized into: 
1. Accreditation Participation Requirements; 
2. Patient-Centered Standards: 
 International Patient Safety Goals 
 Access to Care and Continuity of Care 
 Patient and Family rights 
 Assessment of Patients 
 Care of Patients 
 Anaesthesia and Surgical Care 
 Medication Management and Use 
 Patient and Family Education 
3. Health Care Organization Management Standards: 
 Quality Improvement and Patient Safety 
 Prevention and Control of Infections 
 Governance, Leadership, and Direction 
 Facility Management and Safety 
 Staff Qualifications and Education 
 Management of Information 
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JCI also presents a certification programme, named “Clinical Care Program Certification” 
(CCPC), centred on the assessment of diseases’ management. However, the organisations can 
only apply for this programme when accreditation has been obtained [10, 43, 48-52]. 
 
2.2.1.3 Agencia de Calidad Sanitaria de Andalucía (ACSA) 
This public entity belongs to Ministry of Equal, Health and Social Politics of Andalucía, Spain. 
Its central aim is the promotion of the Quality Model of Andaluz. 
This programme is the official and national model for Portugal, since 2009, based on 
Governmental Order Number 69/2009 31st August. [25] 
In Portugal, there is a department dedicated to quality in health care named “Departamento 
da Qualidade na Saúde” (Department of Quality in Health), being part of the DGS. 
This model provides accreditation, depending on the applicant’s will, to all services or only to 
a few.  
This programme is based on 3 pillars of management: 
 Management by Processes; 
 Clinical Management; 
 Management by Competences. 
This programme also aims to improve the patient’s safety, to ensure competent human 
resources, a better medicine practice and a better measurement and analysis of the outcomes.   
This model is associated with an informatics platform, to facilitate the process of 
communication between auditors and the applicant company and to improve the insertion of 
data, reducing time and costs.  
This model is organized on the topics presented in Table 2: 
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Table 2 - ACSA model 
 
I. The citizen, as the centre of the Health 
System 
1. Patients: Satisfaction, Participation and Rights 
2. Accessibility and Continuity of Health care  
3. Clinical Documentation 
 
II. Integration and Continuity of Health care  
4. Management of healthcare processes  
5.  Activities to Health Promotion 
6. Leadership of the organisation 
III. Professionals 7. Professionals, Education and Evolution  
 
IV. Support Areas 
8. Structure, Equipment, and Suppliers  
9. Systems, Information and Communication 
Technology  
10. Quality Systems 
V. Outcomes 11. Key outcomes in the organisation 
 
For each of these topics there are several requirements, classified into group I, II or III. In 
group I, there are standards considered mandatory.  
This model, contrarily to the others, present three accreditation levels depending on the 
compliance of standards of group I, II and III (Table 3).  
 
Table 3 - ACSA Accreditation levels 
 
 Good Great Excellent 
Group I 
Nº Standards: 65 (from 
which  35 are mandatory) 
 
> 70% (including all the 
mandatory) 
 
100% 
 
100% 
Group II 
Nº Standards: 29 
  
>40% 
 
100% 
Group III 
Nº Standards: 18 
   
>40% 
 
This program has four phases: the request submission to be accredited, the self-evaluation, 
the external assessment and the follow-up (lasting for 5 years, after accreditation, with 
follow-up visits at second and fourth year [10, 43, 53-55]. 
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2.2.1.4 Organisation of European Cancer Institutes (OECI) 
The OECI is a non-profit non-governmental organization created in Vienna in 1979, aiming 
the improvement on oncological care. Its purposes focus on the increase and improvement 
of communication and collaboration between European cancer institutes.  
This organization, already encompasses 68 oncological centres.  
The subgroup named “European Economic Interest Grouping” (EEIG) applies its efforts and 
interests in oncology-related areas. This way, they develop the oncology model that present 
as principal objectives the cancer centres accreditation, elaboration of clinical guidelines, 
education and training, creation of new technologies and development of pathobiology 
studies.  
Part of EEIG’s mission consists on the increase of “Comprehensive Cancer Centres” which can 
be defined as cancer centres that implemented efficiently the oncology model, proving that 
they are competent, capable and have the required resources and equipment to increase 
and improve the oncological care.  
In Portugal, IPO-Coimbra, IPO-Porto and IPO-Lisboa are already associated members of this 
organization.  
The oncology centres that show interest in becoming members of this organization have two 
options with two different financial amounts (Table 4): 
Table 4 - OECI members' fees 
 “Full Member” “Associated Member” 
Admission fee 5.000€ 5.000€ 
Annual fee 5.000€ 2.000€ 
 
The accreditation programmed was developed on 2008 and are accomplished by the 
assessment of two surveys: qualitative and quantitative, supported by an informatics tool.  
This programme requires a primary phase of centre’s designation on the following: 
  “Cancer Units” – Clinical institutions or hospitals that have at least radiotherapy 
and chemotherapy services or oncological surgery; 
 “Clinical Cancer Centre” – Clinical institution with radiotherapy, chemotherapy, 
oncological surgery and some clinical research projects; 
 “Cancer Research Centre” – research unit which develops essentially clinical or 
fundamental oncological projects; 
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  “Comprehensive Cancer Centre” 
The accreditation processes, usually, lengths 9-12 months, being only advisable its beginning 
after the unit achieves a minimum level of quality that can be assessed on the self-evaluation 
phase.  
This way, this model presents the following steps: 
1. The centre applies for OECI, sending the required documentation; 
2. Payment of Phase 1 Fee; 
3. Explanatory visit and Designation process; 
4. Self- Assessment by oncological centre; 
5. Go/No Go decision; 
6. Payment of Phase 2 Fee; 
7. OECI analysis available documentation and proceeds a local audit with 
several auditors (peer-review visit). Checks if the designation was 
appropriate; 
8. OECI assesses the audit results and the submitted documentation; OECI 
divulgates results and comments; 
9. The oncological centre must develop an Improvement Plan; 
10.  If pre-defined compliance with standards, emission of the accreditation 
certificate and formal designation by OECI; 
11. Follow-up process; 
12. At the end of 4 years, after accreditation achievement, the process needs 
to renewal.  
The accreditation model presents the following standards (Table 5): 
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Table 5 - OECI's standards 
Chapter Standards 
Chapter 1: General Standards, Strategic Plan and 
General Management  
26 standards 
121 sub standards 
Chapter 2: Screening, primary prevention and 
Health Education  
5 standards 
19 sub standards 
Chapter 3: Care  10 standards 
30 sub standards 
Chapter 4: Research, Innovation and 
Development   
14 standards 
45 sub standards 
Chapter 5: Education and teaching 4 standards 
45 sub standards 
Chapter 6: Patient Related 6 standards 
30 sub standards 
 
In total there are 65 standards and 264 sub standards. On the qualitative survey, these 
standards can be assessed into: “yes”, “mostly”, “partially”, “no”, or “not applicable”. In the 
quantitative survey there are also fields to fill related to chemotherapy, radiotherapy, 
surgery, research, general management, among others [56, 57]. 
 
2.2.2 Certification 
Certification is the voluntary process for which an external company verifies the fulfilment of 
certain requirements and produces an evaluation report that if positive gives a written 
assurance that a process, a system or service provided by the applicant company is in 
compliance with the reference requirements and the applicable regulatory legislation [10, 31, 
33, 34]. 
In the healthcare sector, certification usually applies to individuals, programmes or services, but 
could also apply to entire healthcare organisations [41, 42]. 
Certification of the healthcare unit is a subsequent process of accreditation, therefore, here, 
there will only be considered the certification of the QMS, which can be achieved before general 
accreditation.  
The search and effort to achieve certification of the QMS brings several benefits to the applicant 
company.  First, and considering the organizational and structural point of view, it contributes 
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to the organization and structuring of the procedures, processes, documentation and operating 
mode of all company departments, enhancing its efficiency. On the other hand, it aids the 
company to comply with regulatory legislation. Besides, it enhances the relations with all 
stakeholders, improving the costumer’s confidence. In addition, the companies reduce the costs 
of non-quality and non-conformities, achieving company’s profitability [30-34]. 
The organization ISO (International Organisation for Standardisation) is a non-governmental 
entity which creates and develops international standards with the aim of increasing quality 
levels in the companies, through processes standardization [58]. 
The ISO 9000:2005 standard contains information about “Fundamentals and Vocabulary”, 
supporting the implementation of quality management systems.  
The NP EN ISO 9001:2008 (Portuguese and European Standard) clarifies the requirements and 
basic principles that a quality management system should obey, focusing on the following: 
 Documentation: organization, management and control; 
 Responsibility of the management/leadership; 
 Resources Management; 
 Development of the Product/Service; 
 Measurement, Analysis and Improvement [30, 32, 59]. 
The process of certification of QMS, by ISO standards includes the phase of documentation 
analysis and supporting/preparation visits, followed by the audit visits and verification  of the 
requirements fulfilment, ending with the final report which encompasses the final decision: to 
be certified or not. The certified organization is submitted to follow-up audits every year. At the 
end of three years, the organization is submitted to renewal visits [60]. 
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3 Activities developed during Traineeship 
The traineeship started at 2nd of June 2014 during the construction phase of Lenitudes MC&R. I had 
the opportunity to follow the Lenitudes MC&R development. In fact, this was a great opportunity 
for me to learn the requirements and equipment needed for several clinical rooms: consultation, 
chemotherapy, preparation of cytostatic agents, radiotherapy and nuclear medicines, surgery and 
even the equipment’s washing, disinfection and sterilization flows, among others. I learnt what 
“outpatient clinic” means and its services and characteristics. I followed the whole process from 
the clinic construction until its opening and start functioning.  
The traineeship core was quality management activities, including the elaboration of the Quality 
Management Plan, initial Quality Management Manual, SOPs and standard records. Additionally, 
there were performed multidisciplinary activities that encompassed the tasks related to the contact 
with suppliers, budget proposal requests and several meetings that were important to define 
equipment and other aspects important to clinic’s functioning. The time-chart of activities 
developed during traineeship is presented in Figure 11. 
In the next sections are presented the activities related to quality management activities and to 
multidisciplinary activities.  
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Figure 11 – Timechart of Activities developed 
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3.1 Quality Management Activities 
In order to be better prepared to perform quality management tasks, I attended to some training 
courses, which will be referred further on the chapter 4 “Training Sessions”. Reading and 
understanding ISO standards were essential such as research and knowledge of the four 
accreditation models mentioned in previous chapters.  
The Quality Management Activities included the development of the following documents: 
1. Quality Management Plan for Lenitudes health units; 
2. Standard Operating Procedure for documentation control; 
3. Quality Management Manual; 
4. Standard Operating Procedure for internal Training Sessions; 
5. Standard Records related to Internal Training Sessions: 
 Standard Record for Quality evaluation of internal Training Sessions; 
 Standard Record to Register Attendance; 
 Standard Record to Register summary and other observations; 
 Standard Record to promote the Annual Training Sessions Plan; 
 Standard Record to assess efficacy of internal Training Sessions; 
 Standard Record to fill the trainer academic information; 
 Standard Record to enrol participants; 
 Standard Record for survey of training needs; 
6. Standard Operating Procedure for reception and maintenance of medical 
equipment; 
7. Standard Records related with maintenance of medical equipment: 
 Standard Record for Technical Assistance Report; 
 Standard Record to register the calibration and verification of medical 
equipment; 
8. Standard Operating Procedure for QMS review; 
9. Standard Operating Procedure to receive and accept clinical trials and studies; 
Every document developed was according to “keep it simple (KIS)” philosophy to ensure that it 
will be easily understandable by all collaborators involved.  
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3.1.1.Quality Management Plan for Lenitudes’ health units 
Initially, I was asked to create an Accreditation Plan for Lenitudes’ units. However, I took into 
consideration the phase in which Lenitudes’ units were. Lenitudes MC&R is still on the 
development phase, not being operating at the date of creation of the plan and without a quality 
management system. Even Lenicare, that is already operating, does not have any QMS created 
and implemented. In order to proceed with accreditation, the health unit must be operating, 
organised and have a QMS implemented, with clinical and quality data, and its analysis of several 
months. This way, in that initial phase, I thought it was not feasible and useful to create an 
Accreditation Plan. Instead, I proposed and developed a “Quality Management Plan” to initiate 
the strategy towards quality. This plan includes a description of the importance of quality to 
Lenitudes’ health units, a general framework with a basic explanation of what is quality, and the 
accreditation and certification processes. In this plan, it is presented the four accreditation 
companies with a brief description of each and their advantages and disadvantages for this 
company. The certification processes presented in this document were based on the 
certification of QMS by ISO 9001:2008. 
The plan also encompasses the strategy for quality and the planning of tasks to achieve it in 
Lenitudes. This strategy was developed by me and reviewed by Prof. Francisco Pimentel, and 
refers the approach that Lenitudes should have towards quality.  
 
Considering the accreditation processes, regarding Lenitudes MC&R’ characteristics, as an 
ambulatory oncological healthcare unit, the CHKS programme considered more suitable was 
oncological programme, presented before on chapter 2.2.1.1. 
CHKS was contacted in order to present a cost estimative of the programme for Lenitudes 
MC&R. It consists of approximately 39.800€ for accreditation and certification and 37.600€ for 
accreditation only, including the expenses related to travelling, accommodation and food.  
 
The JCI’s programme considered more suitable was ambulatory care. The price estimated for 
ambulatory care units given by JCI was approximately 16.299, 70€, without the costs associated 
to travelling, accommodation and food. It is estimated, that this cost will be higher at the end of 
accreditation with the inclusion of all expenses and the value calculation to all services. The 
certification programme costs on average 5.609, 25€.  
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The ACSA is the national accreditation model that shows total agreement with the Portuguese 
legislation. According to an expert contacted, this model used to present costs for public hospital 
accreditation of approximately 5.000€, including all the expenses related to audits. Nowadays, 
it can present higher costs and the costs for private units could be very different, therefore it 
was not possible to assess a precise value.  
 
The OECI model is a specific oncological programme. This model is very specific for cancer 
dedicated centres, having a large group of criteria that are very specific and detailed. Lenitudes 
MC&R would be considered “Clinical Cancer Centre” or “Cancer Unit” depending on several 
factors (such as number of beds, specialists, scientific publications and the budget for care and 
research)  which, according to Table 6, could have a cost from 25.000 to 35.000€ if non-member 
(Table 6).  
Table 6 - OECI's Accreditation costs 
 Cancer Units Clinical Cancer Centres Comprehensive Cancer 
Centres 
Members 20.000€ 30.000€ 30.000€ 
Non-Members 25.000€ 35.000€ 35.000€ 
 
 
In terms of certification, the ISO standards which were considered important to Lenitudes, based 
on the phase of development of the healthcare units and knowing that they don’t have, yet, any 
quality management system, are: NP EN ISO 9000:2005 and NP EN ISO 9001:2008.  
The IPQ (Instituto Português da Qualidade) was contacted in order to obtain information about 
the cost of the NP EN ISO 9001:2008, which turned up to be 40,00€.  
The company SGS (Société Générale de Surveillance) presented a budget for quality 
management system certification through ISO 9001:2008 standards, of 3.000, 00€ for phase 1 
and 2 audits excluding the costs related to accommodation, travel, food and attendance audits. 
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3.1.1.1  Advantages and Disadvantages of Accreditation Models 
The comprehension of accreditation concepts started right on the traineeship’s beginning, 
although the activities developed towards quality started only in December 2014, and 
predominantly in January and February 2015. I also participated in a meeting with CHKS 
members Moyra Amess (Director of Accreditation unit) and Ed Watchorn (Business Manager), 
where they presented their accreditation model. 
 
Concerning CHKS, their online site is a little confused and it is hard and difficult to find 
information related with accreditation and certification programmes, in comparison to JCI and 
ACSA. When they were contacted via email, they proved very available, sending the requested 
information straightaway.  They even appointed a meeting and visit to Lenitudes MC&R that 
occurred at 9th April 2015.  Because of the fact that CHKS presents a programme that includes 
both accreditation and certification allowing the achievement of these processes through high 
standards of quality in health care and on quality management, they present a big advantage 
when compared to JCI, ACSA and OECI. Adding the fact that within accreditation programme, 
there is one plan specific for units with Lenitudes MC&R’s characteristics – oncology. The price 
is similar to OECI’s. One disadvantage is the fact that CHKS is much known in Europe but not 
worldwide. This can impact on the number of foreign clients and in “Health Tourism”.  Another 
disadvantage, by the analysis made to the standards available, is that CHKS program should 
include more requirements for healthcare performance indicators and requirements for 
healthcare procedures outcomes, specifically in chemotherapy and outpatient services [43, 45-
47] . 
 
Regarding JCI, this company also showed very available and send the information required 
when contacted. Their site is also very friendly, allowing access to a few standards and 
definitions, making the understanding process a lot easier. 
The big advantage of JCI is its big reputation in healthcare sector, presenting a very complete 
programme, being considered important for Lenitudes, specifically to achieve “Health 
Tourism”. However, this programme is not appropriate for healthcare units that are in 
development phase. Adding the fact that this model, in spite of being more economic than 
CHKS, it is still expensive and needs higher amounts of financial resources. This company also 
does not present specific models for oncological units [43, 50-52]. 
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In regard to ACSA, the first advantage is related to the fact that this model is the accreditation 
official model for Portugal, showing that it is in complete accordance with the Portuguese 
legislation. Besides, the model was developed by Spain, for a population that is very similar in 
terms of epidemiology to Portuguese population [43].This model is also a lot simpler than JCI’s, 
presenting less requirements, and three accreditation levels, being more attractive to units 
with Lenitudes’ characteristics and phase of development. However, ACSA model is not known 
worldwide, which presents a disadvantage in the “Health Tourism” and internationalization 
aspects. On the other hand, according to an expert contacted, it has not been any healthcare 
private unit accredited by this model [10, 43, 44, 54, 55]. 
 
Concerning OECI, the model might be a good option for Lenitudes MC&R, since it was 
developed completely focused on cancer care. The standards seem to cover all aspects related 
to oncology care, including research that fails to be present on the majority of other models. 
The costs of this programme are very similar to CHKS’s. It can be added that OECI gives 
accreditation for a period of 4 years, contrarily to the three years period of CHKS and JCI. OECI 
is not well known globally, not being appropriate for “health tourism” promotion and 
marketing. On the other hand, this model is only feasible if Lenitudes prefers to acquire this 
service from different entities, one for Lenitudes MC&R and Lenicare and another 
accreditation company for Hospital de Setúbal and Portimão, since OECI only grants 
accreditation to oncological institutions. If Lenitudes decides to acquire this service to only one 
company, OECI will not be an option [56, 57]. 
Comparing the accreditation programmes, CHKS also presented an oncology programme, 
however I could only had free access to a few standards. Therefore I cannot give a precise 
disclosure on if it is very completed and totally appropriate to Lenitudes.   
JCI presented the most economic proposal, but it only presented to “ambulatory care” and by 
adding the expenses related to audits and services that Lenitudes has, it can increase near the 
35.000€. Still, JCI does not have an “oncology programme”, in replacement, it has an 
“ambulatory programme” that may not cover all aspects of oncological treatment.  
OECI seems to be of interest for Lenitudes MC&R to become an associate member, 
independently of accreditation process, to increase their presence among European members. 
 
With reference to QMS certification through ISO standards, this procedure helps the company 
to organise, develop and consolidate the QMS. It is also important to improve the unit’s image. 
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However, this type of certification is specific only for quality management system and not for 
clinical indicators and standards. This way, the certification of QMS can be important to 
structure a healthcare unit, in initial phases. Then it is important to evolve to accreditation of 
clinical activities [30, 32, 34, 36]. 
 
3.1.1.2  Strategy defined 
Considering the phase of Lenitudes’ health units, it was proposed, first, to create the QMS, as 
also as the development of measurement and assessment methods of outcomes regarding 
quality, financial and clinical management. This QMS must be in accordance with ISO standard 
9001:2008 and another applicable ISO standards. It must be taken into consideration that a 
new version of these standards will come during the 2015 year.  
The OECI model, since it is available in its online site, it is advisable to be used at least as basis 
to develop methods to measure and assess clinical outcomes.  
After a minimum period of six months of QMS implementation, and after a detailed analysis 
of suitability, Lenitudes may ask for certification by ISO 9001:2008. A certification plan must 
be developed before any formal submission.  
Then, in a more advanced phase, and depending on the Lenitudes progress towards quality, it 
must be submitted the accreditation request. In this phase, an accreditation plan must be 
developed with a new analysis of costs and advantages and disadvantages of each 
accreditation company. The accreditation company must be selected according to Lenitudes 
defined strategy: if only one accreditation company to all units (JCI showed more positive and 
presented strong advantages), or different accreditation companies specific for each unit (OECI 
for Sta. Maria da Feira and Évora, and JCI for Setúbal and Portimão). 
It was also suggested that Lenitudes MC&R should become associate member of OECI, to 
increase its presence towards oncological care.   
This quality management plan also includes a more detailed planning of tasks by showing the 
order, task description, duration period and correlation between them to create and 
implement an appropriate and efficient QMS and to achieve high levels of quality in Lenitudes 
services [30, 33, 34, 43, 45-52, 54-57, 61].  (See annex 1) 
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3.1.2 SOP for documentation control 
The SOP for documentation control is essential to develop all documents related to quality 
management. Therefore, it must be the first document to be created, as referred in Quality 
Management Plan. Its development was based on ISO 9001:2008, specifically topic 4.2 
“Documentation requirements”. It aims to ensure that current documents and late versions are 
correctly identified, that all documents have a person responsible for their creation, revision and 
approval. The external documents must be identified as such. The obsolete documents must be 
properly identified, in order to prevent their misuse. The records of documentation are also 
defined on this SOP. In this document, it is defined the standard structure that all documents 
must comply with. One example of a structure defined in this document, specific for the 
following types Policy, Plan, Procedure, Protocol, Agreement, Work Instruction and Safe 
Instructions, is presented next: 
1. Scope; 
2. Objectives; 
3. Field of application/ Recipients; 
4. References; 
5. Definitions; 
6. Responsibilities; 
7. Description; 
8. Revision Frequency; 
9. List of Revisions; 
10. Annexes. 
The responsibilities related to documentation development and revision belong to 
Administration Council and its secretary, service/department coordinator or collaborator within 
a service, depending on the document’s type. The conformity assessment is of quality manager’s 
concern while approval of all documents can be of Administration council or clinical director’s 
responsibility.  
Concerning organization and codification of documents, they must be named according to: 
 Healthcare unit where they are inserted (Lenicare or Lenitudes MC&R); 
 Major areas such as Management, Clinical or Support Services; 
 The concerned Service within major areas such as Financial, Quality, Oncology, 
Radiotherapy, or Pharmacy, among others; 
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 Documents’ type – the documents can be classified, according to their content, 
importance, mandatory character and recipients into 5 levels that include the 
following: level 1 (Policy, Regulation, Standard, Information) level 2 (Manual) 
level 3 (Agreement, Plan, Procedure, Protocol) level 4 (Work instructions, Safety 
instructions Safety Data Sheet, Information leaflet, External Document) and 
level 5 (Records); 
 Date of Approval. 
This results in a sequence of 16 numbers separated by dots, as shown in the next scheme: 
 
___ ___.  ___.  ___.  ___ ___. ___    ___   ___. ___. ___ ___. ___ ___. ___ ___ 
 
 
 
 
 
 
 
 
 
 
 
This way a possible code would be: 
Example: 11.2.6.07.001.01.22.12.14 
This is a document from Lenitudes MC&R, from clinical area, subgroup of nursing, plan, number 
001, 1st version approved in 22th December 2014. (See annex 2) 
Regarding the structure, the header and footer of the document are also essential, being 
clarified in this SOP. 
The dissemination and distribution of documents should be controlled and standardised and is 
also present in this procedure.  
The documents in “experimental phase” must also be identified as such.  
The process of storage and control of records must also be defined and standardise for all units, 
being presented and explained in this procedure.  
Connected to this procedure are the examples of formatting for safety data sheets, for records, 
standards and information and the standard for list of QMS documents, external documents and 
applicable legislation.  
This document must be reviewed at least once a year. 
Healthcare 
Unit 
Specific Service  
Document’s 
Type  
Document’s 
Number 
Version 
Number 
Date of Approval: Day. 
Month. Year 
Major Area 
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This SOP was developed with the collaboration of Clinical Director and Chief Nurse [30, 32, 62, 
63]. (See annex 2) 
 
3.1.3 Quality Management Manual 
I developed an initial version of the Quality Management Manual. This document is essential for 
unit’s organisation and structure. It aims to guide the care services in order to ensure a more 
sustainable management, increase collaborator’s motivation and satisfaction and increase 
customer’s confidence. It represents the quality management system that was created and 
implemented in an organisation.  
It was developed in accordance with ISO 9001:2008 and ISO 9000:2005. It includes a brief 
description of Lenitudes’ structure and organigram. There are some information that weren’t 
available and in these sections of the manual a sentence saying “To be defined by Administration 
Council later on” is presented.  
This document presents information about the main responsibilities of CA, Technical 
Commissions, Clinical Director, Department/Medical Specialties’ coordinator, Collaborators in 
general and the person responsible for quality.  Then, the Manual explains in a general view the 
Quality Management System, with information about documentation control, management 
responsibilities, care, research and development, purchases, equipment’s verification and 
calibration, measurement, analysis and improvement, data management and continuous 
improvement. This document must be reviewed at least once a year, but considering the 
Lenitudes phase of development, it should be updated every time a new information is identified 
and approved.  
The process that represents quality management system is schemed next (Figure 12):  [30, 32, 
64, 65] 
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3.1.4 SOP for internal Training Sessions 
This procedure was considered also very important, on the beginning of QMS development, 
since the clinic was going to admit new employees who need to have training sessions, at least 
to learn how to use new medical equipment. This procedure unifies the rules concerning to 
Internal Training Sessions’ documentation. Internal Training Sessions are sessions requested 
internally by the clinical unit, which could have collaboration of external entities. External 
sessions are not covered by this document.  This document is in compliance with SOP of 
documentation control and ISO 9001:2008, having as responsibilities, mainly the human 
resources and the trainers. This procedure has several standard records, in order to keep 
documentation organized, tracked, and updated. It encompasses the process of needs’ 
identification of training sessions, provided by all collaborators, the development of the Annual 
Training Sessions Plan, the disclosure of Training Sessions, the application process, applications’ 
Figure 12 - Scheme representing the process of quality management 
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records, the documentation required to be fulfilled after each session, the evaluation of efficacy 
and quality of the session, 
All collaborators must be responsible to keep their curriculum vitae updated and they should 
share this information with human resources.  
This document should be reviewed at least once a year, if there is no indication on the contrary.  
In order to meet the requirements present in Internal Training Sessions procedure, the following 
standard records were created and must be used always for issues related to Training sessions: 
Standard Record for Quality evaluation of internal Training Session; Standard Record to Register 
Attendance of internal Training Sessions; Standard Record to Register summary and other 
observations of internal Training Sessions; Standard Record to promote the Annual Training 
Sessions Plan; Standard Record to assess efficacy of internal Training Sessions; Standard Record 
to fill the trainer academic information; Standard Record to enrol participants on internal 
Training sessions; Standard Record for survey of training needs [30]. 
 
3.1.5 SOP for reception and maintenance of medical equipment 
This procedure is also in accordance with standard of documentation control. It was written in 
compliance with ISO 9001:2008. It bases on two types of maintenance: preventive and curative. 
This is also an important document, taking into consideration that the clinic was in a phase of 
reception and testing of material. The responsibilities belong mainly to Service of Installations 
and Equipment Maintenance (SIES) and management of equipment department. Borrowed 
equipment should be identified as such. This document also presents a review periodicity of a 
year [30, 66, 67].  
In order to proceed in accordance with reception and maintenance standard procedure I 
developed two standard records, for technical assistance report and for equipment’s calibration 
and verification, in order to register the actions performed, name and code of equipment and 
the responsible collaborator, among others [30, 66, 67]. (See annex 3) 
 
3.1.6 SOP for QMS review 
This procedure is extremely relevant to ensure that QMS is updated and in accordance to 
predefined objectives and to costumer’s expectations. It is also important to achieve continuous 
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improvement. The responsibilities belong to Administration Council (AC) Clinical Director, Data 
Manager, Quality Manager and Financial Department. 
In this procedure it is defined the inputs to improve QMS such as information suggestions 
provided by the collaborators, the audits and inspections’ outcomes, costumer’s opinions and 
complaints, clinical outcomes, quality indicators, financial indicators, preventive and curative 
actions’ outcomes and oldest versions analysis. The outputs consist of improvement of 
documents, processes, and quality of overall service.  
The QMS should be reviewed continuously, but a more detailed and deep analysis should be 
perform at least once a year, preferably at the 3 last months of the year[30, 68]. 
 
3.1.7 SOP to receive and accept clinical trials and studies  
This document, contrarily to the others, were not developed because it was important for the 
initial construction of QMS. Instead, this procedure was created, because I have interest in 
research issues and with my background knowledge on this concept, I was able to develop it 
easily. This way, the document will be ready when needed.  
This procedure aims to standardise the tasks related to clinical trials and studies in Lenitudes’ 
units. It is in full compliance with Portuguese Law nº 21/2014, 16th April, with Directive 
EC/2001/20 and ICH Guideline for Good Clinical Practice (GCP). In Definitions section of the 
document, it is given a clarification of certain concepts such as “Clinical Research”, “Clinical 
Trial”, and “Clinical Study with or without intervention”. The responsibilities, according to GCP, 
belong to Medicines and Medical Devices Portuguese Authority, named Infarmed, the 
Competent Ethics Committee (CEC), that can be Ethics Committee for Clinical Research 
(Comissão de Ética para a Investigação Clínica -  CEIC in Portuguese) or other appointed or a 
local Ethics Committee, depending on the type or research, trial, study with intervention or non-
interventional study, Data Protection Commission (CNPD), Sponsor and Clinical Research Team. 
Then, it is proposed several steps with a predefined order that may not be exactly what is stated 
in the procedure, because this depends and varies according to the sponsor and the type of 
study. The following steps were defined: 
1. Contact between Sponsor and Health Unit; 
2. Shipping of first documentation by Sponsor: including Confidential Disclosure 
Agreement and Feasibility Survey; 
3. Qualification Visit: Assessment of centre’s characteristics and conditions; 
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4. Shipping of more documentation by Sponsor: Study Protocol and Investigator’s 
Brochure; 
5. Shipping of remaining documentation by Clinical Coordinator: Declaration of 
Centre conditions; Recruitment method and Declaration of Compensation; 
6. Sponsor sends the Financial Agreement and CEC, Infarmed and CNPD’s 
declaration; 
7. If applicable, local Ethic committee’s opinion; 
8. Signature and Date on Financial Agreement and on the Protocol by 
Administration Council (AC) and Principal Investigator (PI); 
9. Shipping of all documentation required to regulatory authorities; 
10. Trial’s beginning: if Infarmed’s authorization, CEC favourable opinion, Financial 
Agreement and Study Protocol signed and dated and CNPD’s authorization. 
This document also includes a flowchart with the main steps of this process [30, 32, 69-71]. (See 
annex 4)  
 
3.1.8 Analysis of some Results related with Quality Assessment 
In addition, during three events that occurred in Lenitudes, a Research Meeting, a Visit of UA 
and a training session of software use for physicians, there were delivered surveys to evaluate 
quality of the sessions where the participants filled with their opinions and suggestions. These 
results were, then, analysed.  
The survey assessed during the first event, the Research Meeting that occurred on 10th January, 
had a field to fill with personal information such as name, work location, job and contacts. This 
was important to have access to everyone’s contact numbers to create a data base with this 
information plus the interest of each in research. The second field was about interests of the 
participant in research projects and in specific areas. The third part of the questionnaire 
assessed the interest in participating in future research meetings and a table with some 
evaluation components such as space, schedule, content and organization, which could be 
assessed in a scale of 1 (bad) to 5 (great). The last field was intended for suggestions or aspects 
to improve. This resulted, as referred before, in a data base of names, contacts and interests on 
research that will be of extremely importance to develop future research projects. The results 
concerning quality of the meeting were very positive with an average of 4.79 in a scale from 1 
to 5. There were only two questionnaires not completed filled, with the part of quality 
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evaluation missing to fill. All suggestions were saved and will be taken into consideration for 
next meetings. 
Concerning the second meeting that occurred in 4th February, it consisted of a visit of some 
students of the master degree in Technologies of Medical Image of UA, to learn a few concepts 
regarding Nuclear Medicine and Radiotherapy equipment. There were delivered presence 
records, and Session Summary record. The Quality Assessment survey was divided into four 
moments, corresponding to the four phases of the visit. The Evaluation components were: 
 The subject of the session was of interest; 
 The local was appropriate; 
 The audio-visual equipment was adequate; 
 The schedule was appropriate and complied; 
 The contents met expectations; 
 The knowledge learned is useful for academic and professional career; 
 The trainer complied with objectives and summary predefined; 
 The trainer explained the contents in clear and concise way; 
 The trainer showed available for answering questions. 
There was also space to fill with comments/suggestions to improve.  
Then, the results were analysed. They showed an average of 4.58 in a scale of 1 to 5. The comments 
were very positive, and even used to publish this event on UA’s newsletter. (See annex 5 and 6) 
The record use to fill with summary information was improved, since the space to put trainer’s 
name, signature, company and job tittle was missing.  
The third event that occurred in 6th of April, was assessed similarly to the second referred before, 
presenting a final score of 4.87 in a scale of 1 to 5.  
All of this documentation is properly stored.  
 
3.2 Multidisciplinary Activities 
As referred before, I followed the whole process of construction and opening of the Lenitudes 
MC&R. When I started, in 2nd June 2014, there was only the basic support structure, andeverything 
related to medical equipment, hospital information software, laundry, waste management and 
even security services needed to be chosen and selected. These activities were developed during 
the entire time of traineeship although it focused more on the early months.  
Therefore, in the following sections, I will describe the activities performed, in more detail. 
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3.2.1 Medical Equipment 
 
3.2.1.1 Identification/ Definition of Medical Devices 
Primarily and during the phase of clinics equipment the feedback and opinion from the 
physicians that were going to work in the clinic was essential. The majority of medical devices 
were initially appointed by the Clinical Director and Chief Nurse, based on their experience. 
The medical equipment specific for a certain specialty such as anaesthesia, surgery, cardiology, 
otorhinolaryngology, genecology, urology, pulmonology, nuclear medicine, among others, 
were specifically asked to the future medical coordinator of each medical specialty. I have 
participated on several meetings with physicians to identify needs, to provide catalogues and 
medical devices’ proposals, and to select the preferred equipment.  
The supplier companies were also important sources to identify needs. Based on this 
information lists of medical devices were developed and continuously updated. 
3.2.1.2 Contacting with medical devices suppliers and requesting budgets 
In the first day of internship, it was explained the core of my tasks related to accreditation 
processes advisable to Lenitudes MC&R, and all the other activities that were important to 
ensure that Lenitudes MC&R would have the best equipment at best prices. This way, I was 
requested to search on internet for medical devices suppliers, to make contact with then and 
ask prices for medical equipment. Some companies had already been contacted by Professor 
Francisco Pimentel, in this case I did the follow-up. 
I contacted several medical devices suppliers, listed in Table 7. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
University of Aveiro                                     Pharmaceutical Medicine 
Health Sciences Department                                                                                                    2014/2015 
                       
Page 66 of 103 
 
 
Table 7 - List of suppliers and budgets requested 
Name of the company Medical Equipment budget requested 
 
Actual Way 
 Chemotherapy chair 
 Stretchers 
 Chairs for blood collection 
 More clinical furniture 
Aegen  Chemotherapy chairs 
 
Bacelar 
 
 Clinical furniture (cabinets and benches) 
 Complete Medical Devices’ Catalogue, including , some specific for 
operating room such as Anaesthesia system, Pendent for surgery and 
anaesthesia, surgical table, Mayo, Instrumental and auxiliary table, and 
others needed for the remaining clinical areas such as hospital cars 
(transport, anaesthesia, emergency, and nursing procedures), serum 
holders, vital sign monitors, beds and stretchers and balances  
 
Iberdata 
Bbraun 
 
 Syringes and infusion pumps 
 Some endoscopic equipment 
Cardiosolutions  Equipment for stress and lung function tests 
 
Cenatolim 
 Complete Medical Devices’ Catalogue, including , some specific for 
operating room such as surgical table, Mayo, Instrumental and auxiliary 
table, and others needed for the remaining clinical areas such as 
hospital cars (transport, anaesthesia, emergency, and nursing 
procedures), beds, stretchers, balances and refrigerators 
Salutec 
Endoxim  Equipment specific for otolaryngology specialty 
Eurocasmédica  
 Surgical devices 
 Endoscopic Equipment 
Olympus 
Teprel 
Fresenius Kabi  Syringes and infusion pumps 
 PMH 
Frilabo  Laminar flow hood 
 Refrigerators 
 Blood agitators 
 Microscopes 
Geranswers  Vital sign monitors 
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Iberconcept  Technical Panel for Operating Room 
 
IMO 
 Class I Medical devices such as beds and stretchers 
 Hospital chairs and clinical bedside table 
Industrial Laborum  Clinical furniture (cabinets and benches) 
Johnson & Johnson  Gynaecological equipment 
 Medical Devices washer and sterilization equipment 
LaboSistema  Laminar flow hood 
Maquet  Surgical Tables 
 
Medicinália Cormédica 
 Complete Medical Devices’ Catalog, including , some specific for 
operating room such as Anesthesia system, Pendent for surgery and 
anesthesia, surgical table, Mayo, Instrumental and auxiliary table, and 
others needed for the remaining clinical areas such as hospital cars 
(transport, anesthesia, emergency, and nursing procedures), serum 
holders, vital sign monitors, beds and stretchers. 
 
Mundinter 
MoonSurge  Surgical Medical Devices 
Pulmocor  Equipment for stress and lung function tests 
Remper  Refrigerators 
Sechrist  Hyperbaric Oxygen Therapy Equipment 
Simmedica  Endoscopic Equipment 
SpaceMedical  MAPA (Ambulatory Monitoring of Arterial Pressure) 
Wanrooemed  Chemotherapy chairs 
 
In order to keep medical devices suppliers’ contacts organised and available, I created an Excel 
document with a list of all suppliers, name of the representing person and the respective 
contact.  
The contact with suppliers were made according to the following aspects/steps: 
1. A brief introduction about Lenitudes MC&R, the Lenitudes’ group and the hospital 
units that are under construction; 
2. The importance of the medical devices supplier’s collaboration and their 
partnership; 
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3. The fact that Lenitudes seeks for a global supplier to have the majority of 
equipment at lower prices; 
4. The Companies, then, would make a brief presentation of themselves referring 
their presence on Portuguese and on foreign territory; they would appoint the 
needs and requirements to supply the clinic, delivering a budget proposal to every 
equipment considered important to clinics functioning.  
At late phases, some companies were contacted specifically to present budget for certain 
equipment, being the process referred above a little different.  
Two foreign companies (Aegen and Wanrooemed) were contacted to supply the 
chemotherapy chairs, so I had the opportunity to practice my English and learn that it is not 
advisable to buy medical equipment to a company that does not have a representative in 
Portugal, because of maintenance and assistance matters. Besides, a Portuguese company that 
sells this device was then found.  
I have visited IMO installations, Class I medical devices producer, and I had the opportunity to 
watch closely the production of a hospital bed.  
I have participated in fifty one face meetings with medical devices suppliers. One of those 
meetings was entirely in English language. 
 From all the suppliers contacted (total of thirty one different companies), only thirteen sold 
medical equipment to Lenitudes.  
 
3.2.1.3 Budget Proposals Management 
The budget proposals were delivered via two ways: face-to-face on paper, and digital via e-
mail or pen-drive. 
All the proposals received on paper were digitalised or it was asked to the supplier company 
to send it in digital form through email.  
In my email account, I created a major folder called “Suppliers” with several folders inside 
corresponding to each supplier company. A folder identified as “proposed orders for 
Administration” was created to retain the emails send by me or by Prof. Francisco Pimentel 
with the suggestions of the equipment to buy, to AC’s approval and following acquisition.  
In my computer, I created a major folder, as well, with the name “Suppliers” with several 
folders inside with the catalogues and proposals sent by the companies. 
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3.2.1.4 Prices and characteristics Comparison 
In order to compare the prices from different suppliers, I developed the following Excel 
documents: 
 Excel document with list of medical equipment by room; with information about 
the article number, brand, price for unit and price in total for each supplier. The 
higher prices were represented in red while the lower were on green color. I 
developed fifty one Excel documents with these characteristics specific for each 
clinical room. It was important to have a global vision of the equipment required 
for each room and to negotiate with suppliers (see annex 7); 
 Excel document with list prices by type of medical equipment;  for example one 
document for vital signs monitor device; with information on all suppliers for that 
device, information on article number, brand, price for unit and price in total for 
each supplier. I developed thirty four Excel documents with these characteristics 
for some medical equipment. This was important to facilitate the prices perception 
of a particular device (See annex 8). 
Since in these documents, the prices were easily visualized, they were crucial to 
negotiate with suppliers to obtain lower prices and to choose the supplier company.  
Regarding characteristics of medical equipment, I developed some word and pdf 
documents (in total thirty three) specific for each type of medical equipment with 
devices’ characteristics, images and prices, of each supplier. These documents were 
then sent to physicians that were going to work in the clinic in order to give their opinion 
and feedback.  
 
3.2.1.5 Model and Brand selection 
The decision and selection of devices brand was based on the following topics: 
 Importance and need of medical device; 
 Medical Device’s characteristics and functioning; 
 Feedback from Physician; 
 Price; 
 If the equipment can be included in a global order with a global supplier; 
 Assurance time; 
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 Maintenance and technical assistance time to respond and associated cost; 
 If the equipment is aimed to produce an image outcome, the equipment must 
had the capability of generating the outcome on DICOM format; 
 Every device that generates graphic or parameters should have the capability of 
being connected to Hospital Software through HL7 protocol.  
The process of brand and model selection needed favourable opinion by specialist physician 
and approval by Clinical Director. This process would then be sent, with a clinical 
proposal/suggestion of acquisition, to AC to approve or disapprove this decision and to 
proceed with the following order steps.  
 
3.2.2 Other Equipment and Services important for Lenitudes MC&R 
3.2.2.1 Hospital Equipment 
Certain clinical rooms, such as nursing, pharmacy, chemotherapy, and recovery needed special 
clinical benches and sinks. I participated in this process by communicating with Lenitudes’ 
architect, by transmitting the clinical director’ requirements and ideas, and contacting three 
suppliers: Industrial Laborum, Iberdata and Bacelar. The benches needed to be in inox or in 
corian, an antimicrobial material, with soft texture. The cabinets and respective trays were 
planned to be the same in all rooms, so that it can be easily adapt from ones to another. I also 
participated on the selection and size’s definition of hospital curtains.  
 
3.2.2.2 Hospital Information Software (HIS) 
I participated in several meetings regarding the Hospital Information Software. A company was 
responsible for the global software, another company with a model already predefined was 
responsible to provide software for radiotherapy and chemotherapy. The company that 
develops the global software is also responsible for the connection between all software to 
one, in order to ensure that information is centred in only one software.  
Therefore, the global software should include the Electronic Clinical Process, with billing 
modalities, among others capabilities. It was very important to define the simultaneous users, 
the different access and permissions, which were critical factors to the budget proposal. The 
maintenance and technical assistance were also relevant factors to consider. The integration 
of the software with medical devices was also very discussed and assessed as crucial 
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requirement, especially for endoscopy equipment, vital signs monitors and other cardiac 
equipment. These connections were based on DICOM format of images and HL7 protocol of 
parameters, to ensure interoperability. 
The outputs of this software that are provided to patients or to other physicians was also 
something that needed to be determine, if printed, if delivery through a pen-drive or by giving 
access to a portal on internet.  
 
3.2.2.3  Important Services 
I was required to participate on meetings of budget requests related to waste management, 
laundry, hygiene and cleaning service. The process was very similar to medical devices 
meetings. After receiving their proposals, I developed Excel documents with comparison of 
price and service of each company. Although I did not participated in vigilance and security 
service meetings, I was requested to compare the price of different companies for this service 
as well.  
 
3.2.3 Identification of needs and changes in the clinics structure (Site Visit) 
During the several visits made to Lenitudes MC&R while it was under construction, several 
appointments were made in order to ensure that dimensions were in compliance with legislation 
and standards and to ensure future clinical good functioning. I collaborated in this process by 
giving administrative support to Clinical Director and Chief Nurse.  
I checked the “Recommendations and Technical Specifications for Hospital Units” developed by 
ACSS and Portuguese Governmental Order nº 33/2014” of 12th February, in order to verify some 
clinical rooms, for example if consultation rooms had sufficient electric sources or in what rooms 
it is required to have a sink.  
 
3.2.4 Research & Development 
Although Research and Development (R&D) was not my core activity and in a phase where the 
clinical structure was in construction and development, I still had the opportunity to perform 
some R&D related activities.  
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3.2.4.1 Medical Writing  
I have collaborated as medical writer with Prof. Francisco Pimentel on Scientific Revision of the 
following publications: 
 Laar;, E.S.V., J.M. Desai;, and A. Jatoi, Professional Educational Needs for 
Chemotherapy-Induced Nausea and Vomiting 
 (CINV): Multinational Survey Results From 2388 Healthcare Providers. Supportive 
Care in Cancer, 2014. 
 Pimentel, F.L., Chapter 11 Lifestyle Changes, in Rehabilitation issues during cancer 
treatment and follow-up, H.v. Halteren, Editor 2014, ESMO Handbook Series: ESMO 
Handbook Series. p. 115 - 124. 
I have collaborated on the elaboration of the keywords list of two chapters: 
 Pimentel;, F.L., A. Joaquim;, and S. Custódio, Capítulo 29: Patologia oncológica e 
envelhecimento. Geriatria Fundamental, 2014. 
 Pimentel;, F.L., A. Joaquim;, and S. Custódio, Capítulo 37: Cuidados Paliativos em 
idosos. Geriatria Fundamental, 2014. 
 
3.2.4.2 Collaboration on R&D meetings 
Lenitudes MC&R gives great importance to Research. Therefore it became important to assess 
which physicians and professors would be interesting in collaborating and developing R&D 
projects in Lenitudes.  
The first meeting in Lenitudes MC&R regarding Research and Development occurred in 10th 
January 2015. Professors and Investigators from UA and the future Lenitudes’ collaborators, in 
total twenty six participants, were present in this first meeting.  I have collaborated on the 
meeting organization, being present on the meeting table and, together with Prof. Joana Silva 
from UA, on the development of the meeting minute. I have elaborated a survey as indicated 
before on quality section. After the meeting, I developed an Excel document with a list of all 
participants, with name, function, entity, contact and identification of Research interests, 
according to participant’s answers to the survey. This document were then shared among 
participants.  
The second meeting towards R&D that I have participated was related to a cardiac functioning 
project that occurred in 19th of March. It was mostly to plan the following steps, the definition 
of team members and transmission of the need to improve and adapt the project to increase 
probabilities of financial support within Horizon 2020 Programme. I analysed the draft of the 
  
University of Aveiro                                     Pharmaceutical Medicine 
Health Sciences Department                                                                                                    2014/2015 
                       
Page 73 of 103 
 
 
project and suggested some changes related with the structure of the document, addition of 
information and details, grammatical substitutions and some questions about particular 
aspects of the project, having as basis a form available on “EQUATOR Network” and on the 
knowledge developed during previous experiences and academic acquired during bachelor’s 
and first year of master’s degree [72]. 
 
3.2.4.3 Analysis and Understanding of Horizon 2020 Programme 
Lenitudes is interested on the submission to a Research Financial Support Programme. In 
Portugal, more specifically, on North region there is the “Norte 2020” Programme. However, 
their online site does not provide any specific information about the steps required to 
efficiently submit an application. Then, I searched on European Websites for Horizon 2020 and 
I found four important documents: 
 Commission, E., EC Horizon 2020 Research and Innovation Actions (RIA) Part A and 
Part B, 2014. 
 Commission, E., EC Horizon 2020 AGA Annotated Model Grant Agreement, 2014. 
 Commission, E., EC Horizon 2020 ERC Rules for Submission and Evaluation, 2014. 
 Commission, E., EC Participant Portal H2020 Online Manual: 
http://ec.europa.eu/research/participants/docs/h2020-funding-guide/index_en.htm. 
After reading and understanding of the Horizon 2020 requirements and steps, I developed a 
General Plan for Application’s Submission to Horizon 2020 Programme, which includes the big 
steps required to submit the project: 
 
1. Read all applicable documentation; 
2. Fill the Basic information about the proposal, study duration, keywords and abstract; 
3. Definition of the Work Plan: Identification of work packages, deliverables and timelines; 
4. Assurance of compliance with Ethical Principles; 
5. Guarantee of Research Project’s continuity; 
6. Identification of all partners; 
7. Protection issues: concerning personal data and environmental; 
8. Data Management: identification of data that will be collected; analysis methods that will 
be used, among others; 
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9. Project Management Structure: description of the milestones and timelines; description 
of structure and decision-making 
10. Description of the team members;  
11. Estimation of resources; 
12. Development of a Communication Plan for projects results; 
This plan aims to help to adapt the research projects that Lenitudes will have and to facilitate 
the process of tasks and activities planning [73-76].
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4 Training Sessions 
During traineeship period, I participated on the following training sessions which have been of 
extremely importance to understand better quality related issues. 
The next table lists the training courses that I attended. 
Table 8 - List of Training Courses that I have attended 
Date Tittle Summary Entity Place 
 
3rd October 2014 “IV Fórum ERS - 
Acreditação e 
Certificação em 
Saúde” 
Presentation and 
discussion of 3 
accreditation models (JCI, 
CHKS and ACSA) and 
certification by ISO 
ERS – Entidade 
Reguladora da Saúde 
Fundação Dr. António 
Cupertino de Miranda, Porto 
27-29th October 
2014 
“Auditorias internas a 
sistemas de gestão da 
qualidade de 
dispositivos médicos 
ISO 13485” 
Training Session about 
how to conduct an internal 
audit to QMS of medical 
devices according to ISSO 
13485 
SGS - Société Générale 
de Surveillance S.A 
Pólo De Serviços da Maia 
Rua Padre António, 232 
Fracção 4.4 4470-136 Maia 
11-12th 
November 2014 
“Implementação de 
Sistemas de Gestão da 
Qualidade ISO 
9001:2008” 
Training session about 
how to develop and 
implement a quality 
management system 
according to ISO 
9001:2008 
SGS - Société Générale 
de Surveillance S.A 
Pólo De Serviços da Maia 
Rua Padre António, 232 
Fracção 4.4 4470-136 Maia 
26th November 
2014 
“Gestão de Afinidades 
em instituições de 
saúde” 
Training session 
performed by Prof. Dr. 
Manuel Cardoso Oliveirato 
explain the importance of 
dealing with affinities in 
healthcare 
Universidade Fernando 
Pessoa 
Hospital-Escola da 
Universidade Fernando Pessoa 
Av.ª Fernando Pessoa, 150 
4420-096 Gondomar 
 
20th February 
2015 
“Avaliação Económica 
de tratamentos de 
cancro da próstata” 
Conference about 
economic evaluation of 
prostate cancer treatment 
by a foreign investigator 
CEISUC - Centro de 
Estudos e Investigação 
em Saúde da 
Universidade de 
Coimbra 
Centro de Estudos e 
Investigação em Saúde da 
Universidade de Coimbra 
Av. Dias da Silva, 165   -   3004-
512 Coimbra  -  Portugal 
 
21st March 2015 
 
“Cuidados Paliativos” Presentation about 
palliative care presented 
by Prof. Francisco Pimentel 
in Master’s degree in 
Geriatric 
FMUC – Faculdade de 
Medicina da 
Universidade de 
Coimbra 
Azinhaga de Santa Comba, 
Celas 
3000-548 Coimbra 
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5 Discussion 
During first year of my Master’s degree, I developed knowledge on clinical research and 
development, regulatory pharmaceutical legislation, medical devices regulation, research and 
development, pharmaceutical and health economics, Medical Drugs’ pharmacovigilance, 
systematic review and meta-analysis. I attended to a subject called “Quality Management” on last 
year of my bachelor’s degree that was common to students from health and engineering 
departments. Therefore, this subject was very general, not focusing on topics related to health, 
pharmaceutical or medical devices. At the end of first year of Master’s degree, I felt a lack on quality 
management knowledge.  
When I got the proposal to do my traineeship on Lenitudes MC&R, It was explained to me that this 
was a new health unit that was being built from scratch. It was indicated that top priorities of my 
tasks were medical devices budgets requests, management and organisation of information, 
support to clinical director and chief nurse work, and the core, quality management activities. I got 
very enthusiastic right from the beginning: I was having a very rare opportunity to follow and 
support the creation of a new health unit. At the beginning, for 7 months, the team was very small, 
being only the clinical director, chief nurse, AC (3 members), some Lenitudes holding-members and 
me (in total: 9 people). Therefore I had followed the majority of decisions related to Lenitudes 
MC&R. I followed the budget requests, medical devices’ decision,  unit’s building/ civil construction, 
benches and cabinets decision, visits to clinical unit, commercial name selection (before it was 
called Maio Clinic and now Lenitudes MC&R), curriculum vitae submissions, clinics inauguration,  
information software decision, outsourcing services decisions, among others. Together with the 
enthusiasm it came the fear of the unknown and the start of something new. The closest members 
were, undoubtedly, the clinical director and chief nurse that advised me, supported my activities 
and made easier what seemed to be a difficult but a unique challenge.  
As referred before, the core of my activities was quality related such as the creation of the 
accreditation plan. I already had knowledge on accreditation and certification designations and on 
ISO standards for certification, but health specific accreditation models and organisations were 
completely new for me. The Clinical Director advised me to search for JCI and for national 
accreditation model to start understanding this topic. The Chief Nurse, experienced in auditing also 
provided documentation on JCI and ISO standards and helped clarifying some issues. In order to 
have a better understanding, I have participated in three training courses, one provided by ERS and 
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the other two by SGS. In addition, I visited the quality department of Hospital São Sebastião to 
increase my knowledge towards clinical quality management systems.  
I also contacted, via email, JCI, CHKS and OECI, to obtain more information on these specific models, 
putting into practice and improving my English and communication skills. 
The quality management activities were, truly, a challenge. First, I tried to understand the 
accreditation models alone, clarifying some doubts with the experts, then to understand how a 
quality management system works and the requirements needed for an efficient QMS.  I disagreed 
with the need to develop an accreditation plan on this initial phase, proposing that a quality 
management plan was more important and needed. I set the priorities of procedure development 
such as the documentation control that needs to be created first because it is essential to continue 
the QMS development, then the training procedure and equipment maintenance. I also developed 
a lot of standard records. The difficulties I felt were more related to approval and implementation. 
After the process of understanding and developing the documents, the conditions to proceed with 
approval and implementation of quality procedures were not gathered. Lenitudes MC&R was, still, 
in phase of selection of human resources, of medical devices and outsourcing services. The licences 
required to start operating were also not gathered yet. Nevertheless, each document that I have 
made towards quality, was shared with Clinical Director and Chief Nurse, and waited for new 
advances to be presented to administration council.  
The medical devices management activities were also a great challenge. First, I have learnt how to 
communicate with suppliers, through email, phone and, more important, personally. I have 
participated in several meetings, I have understood the clinical characteristics for each device 
required by the physicians, I have learnt how to assess budget proposals, to give importance to 
clinical characteristics that are evaluated by the physicians and the technical assistance, discounts 
and time of assurance. With these activities I have learnt to be more communicative and specially, 
more organised. I received many budget proposals, and I was the one with the responsibility of 
recording and saving all these documents, including catalogues. I also developed many excel maps 
with list of equipment, suppliers and prices that also needed to be carefully organised. In these 
activities, another skill that I consider very relevant is the ability to pay attention to little details, so 
that none information is missed that could compromise the money spent and clinics functioning.  
In the phase of development where Lenitudes MC&R was, there was quite complicated to ensure 
a correct time management, since there were times where decisions were being made, with tasks 
with extreme restrict schedules that needed to be performed as quickly as possible.  
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Since one characteristic of my personality is being perfectionist, at the beginning I had to deal with 
the fear of failure. This has happened more on medical devices management and requests to buy 
material to administration council, and on the activity of sending important documents to 
physicians. This “fear” had been diminishing as I was doing the tasks correctly.  
During my traineeship, the activities related to medical devices management were transferred to 
another person that will be the responsible for this task. I have maintained quality management 
activities and added the clinical research and development tasks.  
During the traineeship, I also gained more autonomy, regarding contact with suppliers and 
development of quality documents.  
In summary, I think that I have achieved all objectives previous defined concerning master’s degree 
and my host organization aims. I contributed to the successful equipping and functioning of 
Lenitudes MC&R. I have a deep understanding of quality management systems and knowledge on 
some accreditation and certification models. I also know what an outpatient clinic with Lenitudes 
MC&R characteristics needs to have, regarding medical equipment. Furthermore, I know the 
medical devices market and the main Portuguese suppliers and producers.  
Personally, I have developed the following soft skills: organisation and management, ability to work 
as a team, time management, ability to work under pressure, attention to details, responsibility 
sense and autonomy, communication skills, better understanding of my strengths and difficulties, 
adaptation to clinical environment and work schedules.  
I can emphasise that I fulfilled all the objectives predefined, having felt more difficulties in 
management activities regarding quality and medical devices’ budgets.  
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6 Conclusion 
The healthcare marketplace presents a high demand, having the search for Portuguese private 
healthcare services been increasing. Cancer and cancer survivors are also increasing, presenting 
clinical particularities and extra requirements [2, 3, 16, 17]. 
 Lenitudes MC&R is a new health unit that aims to play a greater role towards oncological care, 
research and development projects. It has the ultimate technology concerning radiotherapy and 
nuclear medicine, electroporation and surgery procedures. It will develop several clinical research 
projects, participate on clinical trials, and the data generated will be continuously collected and 
analysed to give more reliable and valuable data, for a more secure and personalised medicine.  
Quality is considered crucial to clinic’s sustainability and growth. It is important for collaborators, 
suppliers, customers and to all stakeholders involved. It is one marketing strategy to attract foreign 
patients. For Lenitudes SGPS Company, the accreditation models evaluated in terms of suitability 
were CHKS’s, JCI’s, ACSA’s and OECI’s, whereas in terms of certification of quality management 
system, the ISO 9001:2008 standard was considered.  
I feel glad for having had the opportunity to do my traineeship in Lenitudes MC&R. I achieved all 
the objectives predefined, and developed strong soft skills. Now I feel adapted to clinical 
environment. I had the chance to put into practice some knowledge acquired during academic 
training related with quality management, medical devices legislation, research and development.  
It made me grow both professionally and personally, making me more organized, communicative, 
autonomous and responsible.  
It was, undoubtedly, a unique challenge that prepared me to have a complete view of the needs 
and requirements for a clinical unit to be equipped, to be in compliance with the applicable 
legislation and to start operating and functioning.  
Therefore, I can conclude by emphasizing the fact that now I feel that I have the abilities and skills 
needed to face the labour market.  
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8 Annexes 
Annex 1: Quality Management Activities Planning 
Table 9 - Quality Management Activities Plan 
Tarefa Descrição Duração Período de Tempo após Aprovação do 
Plano 
Observações 
 
 
 
 
 
 
1 
Reunião para Discussão do Tema “Qualidade” e 
Apresentação deste Plano: 
o Identificação de possíveis alterações ao Plano 
o Aprovação do Plano  
o Identificação da Equipa da Qualidade (pelo 
menos 6 elementos) 
 Coordenador 
 Gestor da Qualidade 
 Elementos de ligação (para 
colaborarem em algumas tarefas 
relacionadas com a qualidade, 
nomeadamente, reuniões, 
procedimentos de revisão e 
auditorias internas) constituídos por 
1 colaborador de cada unidade  
 Grupo de Trabalho Local: Equipa com 
elementos de todas as áreas 
 
 
 
 
 
 
2 Semanas 
 
 
 
 
 
 
Semana 0-2  
 
 
 
 
 
 
Esta reunião deve ser efetuada até um 
mês antes do início das consultas 
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profissionais de cada uma das 
unidades funcionais 
2 Adquirir a norma ISO 9001:2008 1 Semana Semana 3  Custo ≈ 40,00€ 
 
 
 
 
 
 
 
 
 
3 
Iniciar a criação do Sistema de Gestão da qualidade de 
acordo com a Norma ISO 9001:2008 
 
   
a) Desenvolver o procedimento de controlo da 
documentação e toda a documentação associada; 
Aprovação e Implementação 
3 Dias Semana 3 O procedimento já foi elaborado; Falta 
aprovação e implementação 
Após Execução da Tarefa 1; 
Data Limite: 3 semanas antes do início da 
atividade clínica 
b) Desenvolver o Manual da Qualidade, identificar a 
política e os objetivos da empresa para a 
qualidade 
Aprovação e Implementação 
2 Semanas Semana 3 - 4 Data Limite: 3 semanas antes do início da 
atividade clínica 
c) Desenvolver o procedimento de Ação de 
Formação e toda a documentação associada; 
Aprovação e Implementação 
3 Dias Semana 3 Após Execução da Tarefa 1 e 3a)  
O procedimento já foi elaborado; Falta 
aprovação e implementação 
Data Limite: 3 semanas antes do início da 
atividade clínica 
d) Desenvolver o procedimento de Receção e 
Manutenção de Equipamentos e todos os registos 
associados 
3 Dias Semana 3  Após Execução da Tarefa 1 e 3a)  
O procedimento já foi elaborado; Falta 
aprovação e implementação 
Data Limite: 3 semanas antes do início da 
atividade clínica 
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e) Desenvolver procedimentos de Emergência e 
Transferência de doentes; Aprovação e 
Implementação 
1 Semana  Semana 3  Após Execução da Tarefa 1 e 3a)  
Data Limite: 2 semanas antes do início da 
atividade clínica 
f) Desenvolver procedimentos específicos e de 
apoio às consultas e tratamento de 
quimioterapia; Aprovação e Implementação  
4 Semanas Semana 3 - 7 Após Execução da Tarefa 1 e 3a) 
Data Limite: Imediatamente antes do 
início da atividade clínica 
g) Desenvolver o Plano de Gestão de Risco 3 Semanas  Semana 3 - 6 Após Execução da Tarefa 1 e 3a) 
Data Limite: Imediatamente antes do 
início da atividade clínica 
h) Desenvolver procedimentos específicos e de 
apoio à CIR; Aprovação e Implementação; 
Atualizar Plano de Gestão de Risco 
4 Semanas Semana 7 - 11 Após Execução da Tarefa 1 e 3a) 
Data Limite: Imediatamente antes do 
início da atividade cirúrgica 
i) Desenvolver procedimentos específicos e de 
apoio à RAD e MDN; Aprovação e Implementação; 
Atualizar Plano de Gestão de Risco 
8 Semanas Semana 3-11  Após Execução da Tarefa 1 e 3a) 
Data Limite: Imediatamente antes do 
início o funcionamento do serviço de 
radioterapia e medicina nuclear 
j) Desenvolvimento da restante documentação de 
suporte ao SGQ e atualização da documentação 
necessária 
2 Semanas Semana 11-13  Após execução das Tarefas anteriores 
4 Identificar indicadores de qualidade e métodos de medição 3 Semanas Semana 14 – 16  Após execução das Tarefas anteriores 
5 Análise dos Resultados da Qualidade 8 Semanas Semana 16 – 24  Após execução das Tarefas anteriores  
 
6 Apresentação dos Resultados e identificação de 
oportunidades de Melhoria 
2 Semanas Semana 24 – 26 Após execução da Tarefa anterior 
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7 Identificar necessidade de certificação e seleção da empresa 
certificadora 
 
2 Semanas Semana 26-28  Após execução da Tarefa anterior 
8 Realização e Apresentação do Plano de certificação 2 Semanas Semana 28-30  Após execução da Tarefa anterior 
 
9 Adquirir a nova versão 2015 da norma 1 Semana Semana 30 – 31  Efetuar nova consulta de Preço 
 
10 Verificação do cumprimento de todos os requisitos e 
especificações 
 
6 Semanas Semana 31 – 37  Após Aquisição da Norma e após 
realização da Tarefa 8 e 9 
 
11 
Efetuar submissão do pedido de certificação à empresa 
selecionada 
 
 
2 Semanas 
 
Semana 37 – 39  
Após Execução da Tarefa anterior 
 
12 
Efetuar todos os procedimentos e tarefas necessários para a 
obtenção da certificação do SGQ; 
Obtenção de certificação do SGQ 
 
 
16 
Semanas 
 
Semana 39-55  
Após realização da Tarefa anterior 
 
13 
Após certificação do SGQ, atualizar política, objetivos e 
manuais da Qualidade 
 
 
2 Semanas 
 
Semana 55-57  
 
Tarefa a ser realizada após obtenção da 
certificação 
14 Melhoria de procedimentos e análise de resultados da 
qualidade 
10 
Semanas 
Semana 57 – 67   
 
15 
 
Avaliação da necessidade de acreditação e seleção da 
empresa acreditadora 
 
 
2 Semanas 
 
Semana 67-69  
 
- 
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16 Elaboração e Apresentação do Plano de Acreditação 3 Semanas Semana 69 – 72  - 
 
17 Mediante autorização, proceder à aquisição do manual 1 Semana Semana 72-73  Custo ≈ 127,44€ 
 
18 Verificação do cumprimento dos requisitos e possíveis 
alterações 
30 
Semanas  
Semana 73 - 103  Após aquisição dos Manuais 
 
19 
Efetuar submissão do pedido de acreditação à empresa 
selecionada 
 
 
2 Semanas 
 
Semana 103 – 104  
Após execução da Tarefa anterior 
 
 
20 
Efetuar todos os procedimentos e tarefas necessários para a 
obtenção da acreditação; 
Obtenção de acreditação 
 
32 
Semanas 
 
Semana 104 – 136  
Após Realização da Tarefa anterior 
 
 
- 
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Certificação 
Figure 13 - Time chart of Quality Management Approach 
Acreditação 
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Annex 2: SOP for Documentation Control (first page and some tables presented in this SOP) 
Figure 14 - First Page of SOP for Documentation Control 
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Table 10 - Codification of entities belonging to Lenitudes' Group 
 
Organização: Codificação: 
 
Lenitudes SGPS 01 
Lenicare, Évora 10 
Lenitudes Medical Center & 
Research 
11 
Hospital Cirúrgico Setúbal 12 
Hospital de Portimão 13 
 
Table 11 - Codification of major areas and services of each Lenitudes' unit 
 
Área Código Subgrupo 
 
Código 
 
 
 
 
 
Gestão 
 
 
 
 
 
1 
Conselho de Administração 1 
Comissões/Órgãos Técnicos 2 
Administração/ Secretariado 3 
Recursos Humanos 4 
Qualidade 5 
Financeira 6 
Outros 9 
 
 
 
Clínica 
 
 
 
2 
Oncologia 1 
Radioterapia 2 
Medicina Nuclear 3 
Imagiologia 4 
Cirurgia 5 
Enfermagem 6 
Técnicos Superiores 7 
Documentos Gerais 8 
Outros 9 
Serviço de 
Apoio 
3 Farmácia 1 
Esterilização 2 
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Morgue 3 
Aprovisionamento 4 
SIES 5 
Higiene e Limpeza 6 
Laboratórios de patologia clínica, 
anatomia patológica e genética 
7 
Outros 9 
Outros 9 A definir 1 
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Table 12 - Types of Documents available in Lenitudes' units 
Nível Tipo de 
Documento 
Código Descrição 
 
 
 
 
 
 
 
1 
Política 01 Conjunto de regras e diretrizes definidas pelo conselho de administração 
tendo em conta a estratégia de mercado, visão e valores da empresa.  
 
Regulamento 02 Conjunto de regras, direitos e obrigações de carácter normativo de forma 
a regular a atividade e funcionamento da organização. 
 
Norma 
 
03 Documento elaborado pelo Conselho de Administração de índole 
normativa. 
Informação 04 Documento elaborado pelo Conselho de Administração de cariz 
informativo. 
 
 
2 
Manual 05 Documento que inclui as informações sobre um determinado assunto ou 
equipamento, incluindo instruções e orientações de funcionamento e 
utilização. 
 
 
 
 
 
 
 
3 
Acordo 06 Conjunto de informações relativas à concordância e acordo de um ou 
mais aspetos, celebrado entre as partes interessadas. 
 
Plano 07 Conjunto de orientações e estratégias definidas de forma a cumprir os 
objetivos enunciados na Política e noutros documentos elaborados pelo 
CA. 
 
Procedimento 08 Documento que define e descreve as etapas e métodos necessários para a 
realização de uma determinada tarefa/atividade. 
 
Protocolo 09 Conjunto de orientações e regras que visam um entendimento entre os 
diversos intervenientes. 
 
 
 
 
 
 
 
4 
Instruções de 
Trabalho 
10 Conjunto de esclarecimentos e orientações referentes ao modo de 
execução de uma tarefa/atividade. 
 
Instruções de 
Segurança 
11 Conjunto de orientações de segurança que visam a prevenção, 
minimização, ou eliminação de riscos.  
 
Ficha de Segurança 12 Conjunto de informações relacionadas com um determinado produto ou 
substância no que diz respeito ao risco, utilização/manuseamento e 
condições de armazenamento.  
 
Folheto de 
Informação 
13 Conjunto de informações de caracter diverso, destinado aos 
colaboradores, pacientes, familiares, convidados e visitas. 
 
Documento externo 14 Documento elaborado, revisto ou alterado por uma unidade externa ao 
SGQ.  
 
5 Impressos 15 
 
Documento com campos de registo. 
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Annex 3: Technical Assistance Report 
 
Intervenção 
 
Preventiva 
 
Curativa 
           
                Interna                                 
 
Externa 
 
 
Data de deteção da Anomalia:  
 
 
Se a intervenção for realizada por uma empresa externa, o técnico 
apenas tem que preencher as linhas até à “identificação do documento” 
e a última, ficando responsável por garantir que a empresa externa 
entregue toda a documentação associada. 
Colaborador que detetou a anamolia e contactou o SIES: 
         Nome:  
 
      NºMec.:  
 
Identificação do equipamento: 
 
Nome:  
 
Código:  
 
Localização:  
 
 
Identificação do equipamento: 
 
Nome:  
 
Código:  
 
Localização:  
 
Avaliação do Equipamento 
(de acordo com a ordem apresentada) 
Avaliação do Equipamento 
(de acordo com a ordem apresentada) 
 
O equipamento apresenta riscos para a segurança das pessoas? 
 
Sim                       Não 
 
Se sim, efetuar imediatamente os procedimentos de segurança. 
 
 
O equipamento apresenta riscos para a segurança das pessoas? 
 
Sim                       Não 
 
Se não, efetuar imediatamente os procedimentos de segurança. 
 
 
As infraestruturas e os espaços estão salvaguardados: 
 
Sim                       Não 
 
Se não, avaliar de que forma se pode minimizar os estragos. 
 
As infraestruturas e os espaços estão salvaguardados: 
 
Sim                       Não 
 
Se não, avaliar de que forma se pode minimizar os estragos. 
 
Performance/Funcionalidade do Equipamento: 
 
De 0 a 5 classifique a performance do equipamento, tendo em conta, 
as suas características-base: 
 
1 2 3 4 5 
     
 
Detetou alguma anomalia? 
     Sim                                   Não 
 
 
 
 
 
 
 
 
 
 
Performance/Funcionalidade do Equipamento: 
 
Identificação da falha:  
 
Sugestão de correção e reparação:  
 
 
 
Caso não tenha conseguido identificar a falha, por favor assinale: 
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Procedimentos de manutenção realizados: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
O Equipamento cumpre as normas e está a funcionar corretamente? 
 
Sim                           Não 
 
                             Se não, iniciar intervenção curativa. 
 
 
 
Data prevista da Próxima manutenção: 
 
Procedimentos realizados: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Equipamento reparado: 
 
Sim                       Não 
 
                             Se não, contacte a empresa fornecedora. 
 
Para equipamentos que não foram reparados, existe a possibilidade 
de substituição/compra do equipamento? 
 
Sim                       Não 
 
Se sim, expor a situação ao Diretor clínico e posteriormente ao 
Conselho de Administração.  
 
 
Técnico responsável 
 
Nome:  
 
Nº Mec.:                                                      ____/____/____                                                                                                                
 
                                                                
_____________________                                                      
                                                                          (o técnico) 
 
Técnico responsável 
 
Nome: 
 
Nº Mec.:                                 ____/____/____
 
                                                                
_____________________                                                      
                                                             (o técnico) 
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Annex 4: Schematic Procedure to receive and accept a clinical trial or study 
 
 
Nota: Os documentos e a respetiva ordem aqui representados podem não corresponder exatamente à 
realidade para todos os ensaios/estudos, visto estes poderem ser promovidos por entidades diferentes.   
Contacto Inicial 
•Entre o Promotor e a 
Clínica
Entrega de 
Documentação
• O Promotor entrega:
• Confidential Disclosure 
Agreement
• Feasibility Survey
•Sinopse do 
Estudo/Ensaio
Visita de Qualificação
•Avaliação das Condições 
do Centro
Promotor:
•Envio do Protocolo do 
Estudo/Ensaio
•Entrega da Brochura do 
Investigador
Coordenador de 
Investigação Clínica:
•Elaboração e Envio da 
Declaração das Condições 
de centro
•Elaboração e Envio da 
Declaração de 
modalidade de 
Recrutamento de 
Doentes
•Elaboração e Envio da 
Declaração de 
Compensação
Promotor:
•Envio do Acordo 
Financeiro
•Envio da Declaração da 
CEC, Infarmed e CNPD, se 
aplicável
CES:
•Parecer sobre o Protocolo 
e Consentimento 
Informado, se aplicável
CA e PI
Aprovação do 
ensaio/estudo no centro 
CA e PI: Rúbrica e Data no 
Acordo Financeiro
PI: Rúbrica e Data no 
Protocolo
Promotor:
•Envio de toda a 
documentação para: 
Infarmed (se aplicável), 
CEC, CES, CNPD e Equipa 
de Investigação
Início do 
estudo/ensaio:
•Autorização do Infarmed
•Parecer favorável da CEC
•Acordo Financeiro e 
Protocolo devidamente 
assinados e datados
•Autorização da CNPD
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Annex 5: Results of a Quality analysis to a Training Session 
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Annex 7: UA’s newsletter showing the event of UA’s students visit to Lenitudes MC&R 
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Annex 7: List of Medical equipment by room (in this case surgery room) 
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Annex 8: List of Medical equipment by type of equipment (in this case vital signal monitors) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
